Akcie společnosti Reinsurance Group (RGA) dosáhly 52týdenního maxima na úrovni 258,53 USD; od začátku roku posílily o 25,8 %. Společnost v posledních čtyřech čtvrtletích překonala odhady zisku.
Shares of Reinsurance Group (RGA - Free Report) have been strong performers lately, with the stock up 3.4% over the past month. The stock hit a new 52-week high of $258.53 in the previous session. Reinsurance Group has gained 25.8% since the start of the year compared to the 3.3% gain for the Zacks Finance sector and the 14.7% return for the Zacks Insurance - Life Insurance industry.
What's Driving the Outperformance?The stock has a great record of positive earnings surprises, having beaten the Zacks Consensus Estimate in each of the last four quarters. In its last earnings report on August 6, 2026, Reinsurance Group reported EPS of $8.89 versus consensus estimate of $6.51 while it beat the consensus revenue estimate by 0.95%.
For the current fiscal year, Reinsurance Group is expected to post earnings of $29.71 per share on $26.9 in revenues. This represents a 30.77% change in EPS on a 12.36% change in revenues. For the next fiscal year, the company is expected to earn $29.4 per share on $28.2 in revenues. This represents a year-over-year change of -1.06% and 4.81%, respectively.
Valuation MetricsWhile Reinsurance Group has moved to its 52-week high over the past few weeks, investors need to be asking, what is next for the company? A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself.
On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style.
Reinsurance Group has a Value Score of A. The stock's Growth and Momentum Scores are F and A, respectively, giving the company a VGM Score of B.
In terms of its value breakdown, the stock currently trades at 8.6X current fiscal year EPS estimates, which is not in-line with the peer industry average of 10.9X. On a trailing cash flow basis, the stock currently trades at 12X versus its peer group's average of 9.8X. This is good enough to put the company in the top echelon of all stocks we cover from a value perspective, making Reinsurance Group an interesting choice for value investors.
Zacks RankWe also need to look at the Zacks Rank for the stock, as this is even more important than the company's VGM Score. Fortunately, Reinsurance Group currently has a Zacks Rank of #2 (Buy) thanks to favorable earnings estimate revisions from covering analysts.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Reinsurance Group meets the list of requirements. Thus, it seems as though Reinsurance Group shares could have a bit more room to run in the near term.
Cava Group (CAVA - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this Mediterranean restaurant chain have returned +0.6%, compared to the Zacks S&P 500 composite's +1.3% change. During this period, the Zacks Retail - Restaurants industry, which Cava falls in, has lost 6.8%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
Cava is expected to post earnings of $0.12 per share for the current quarter, representing no change from the year-ago quarter. Over the last 30 days, the Zacks Consensus Estimate has changed -1.2%.
For the current fiscal year, the consensus earnings estimate of $0.55 points to a change of +1.9% from the prior year. Over the last 30 days, this estimate has changed +0.2%.
For the next fiscal year, the consensus earnings estimate of $0.74 indicates a change of +34.1% from what Cava is expected to report a year ago. Over the past month, the estimate has changed -2.9%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Cava is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
In the case of Cava, the consensus sales estimate of $357.82 million for the current quarter points to a year-over-year change of +22.4%. The $1.51 billion and $1.79 billion estimates for the current and next fiscal years indicate changes of +27.7% and +18.9%, respectively.
Last Reported Results and Surprise HistoryCava reported revenues of $368.44 million in the last reported quarter, representing a year-over-year change of +31.3%. EPS of $0.19 for the same period compares with $0.16 a year ago.
Compared to the Zacks Consensus Estimate of $353.31 million, the reported revenues represent a surprise of +4.28%. The EPS surprise was +5.56%.
Over the last four quarters, Cava surpassed consensus EPS estimates three times. The company topped consensus revenue estimates three times over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Cava is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Cava. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
BioMarin předložila FDA doplňující žádost o schválení přípravku VOXZOGO pro léčbu hypochondroplazie; v případě schválení by šlo o první cílenou léčbu s možným uvedením na trh v roce 2027.
New analysis showcases impact of VOXZOGO® (vosoritide) in foramen magnum and craniocervical junction growth in children with achondroplasia, including infants
, /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced it will present new data from 13 studies at the American Society for Bone and Mineral Research 2026 Annual Meeting (ASBMR) in Boston, including results from studies of VOXZOGO® (vosoritide) in children with achondroplasia and hypochondroplasia. The company will also share data from studies of the investigational long-acting medicine BMN 333.
The data include encouraging new imaging results from a post-hoc analysis of a randomized, double-blind, placebo-controlled trial evaluating the effect of VOXZOGO on the growth of the foramen magnum and craniocervical junction in children with achondroplasia, including infants.
"These findings provide important new insight into the potential effect of VOXZOGO on growth-related dimensions of the foramen magnum and craniocervical junction, regions of the skull implicated in cervicomedullary compression and serious complications in children with achondroplasia," said Greg Friberg, M.D., Executive Vice President and Chief Research & Development Officer at BioMarin. "The results also underscore the potential VOXZOGO treatment may offer when started as early as possible, when it can have the greatest impact. Together with the additional data we're presenting on bone strength, limb alignment, and our emerging work in hypochondroplasia and next-generation medicines such as BMN 333, these findings reflect the depth and breadth of our commitment to understanding and improving outcomes for children living with skeletal dysplasias."
BioMarin recently submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for VOXZOGO for the treatment of hypochondroplasia. The company is also on track with its submissions to the European Medicines Agency (EMA) and other regional health authorities. If approved, VOXZOGO would be the first targeted therapy for the treatment of hypochondroplasia, with a potential 2027 launch.
Additional data to be presented at the meeting include research in hypophosphatasia, as well as results from the Phase 3 ENERGY 3 study of BMN 401 in children ages 1 to 12 years with ENPP1 deficiency.
Below are key presentations at ASBMR, with all times listed in Eastern Daylight Time:
C-Type Natriuretic Peptide (CNP) Agonist CNP38 Promotes Longitudinal Bone Growth by Growth Plate Expansion in the Hyp Mouse Model of XLH
Oral Presentation #1138
Monday, Oct. 12, 11:30 – 11:42 a.m.
BMN 333, a Long-Acting Vosoritide Investigational Product, Promotes Endochondral Bone Growth and Skeletal Microarchitecture in Juvenile Mice and Nonhuman Primates
Poster Presentation #092
Friday, Oct. 9, 5:30 – 7 p.m.
Sunday, Oct. 11, 2 – 3:30 p.m.
Examining the Effect of Vosoritide Treatment on Bone Strength in Children With Achondroplasia
Poster Presentation #486
Saturday, Oct. 10, 2 – 3:30 p.m.
Efficacy and Safety of BMN 401 in Children With ENPP1 Deficiency: 52-Week Results From the Pivotal ENERGY 3 Trial
Poster Presentation #554
Saturday, Oct. 10, 2 – 3:30 p.m.
Economic Burden of Hypophosphatasia: A Systematic Literature Review
Poster Presentation #473
Saturday, Oct. 10, 2 – 3:30 p.m.
Development of BMN 333, a Long-Acting Version of Vosoritide for FGFR3-Related Dwarfism and Other Skeletal Dysplasias
Poster Presentation #115
Sunday, Oct. 11, 2 – 3:30 p.m.
Comparison of Quantitative Computed Tomography Bone Mineral Density Measurements of Vosoritide-Treated Children With Achondroplasia to an Untreated Achondroplasia Reference Population
Poster Presentation #474
Sunday, Oct. 11, 2 – 3:30 p.m.
Vosoritide Increases Growth Velocity in Children With Hypochondroplasia: Phase 3 Trial Results
Poster Presentation #552
Sunday, Oct. 11, 2 – 3:30 p.m.
The Effect of Vosoritide on Growth of the Foramen Magnum and Craniocervical Junction in Children With Achondroplasia
Poster Presentation #483
Sunday, Oct. 11, 2 – 3:30 p.m.
Molecular Insights into Vosoritide's Role in Enhancing Bone Growth and Mineralization
Poster Presentation #362
Sunday, Oct. 11, 2 – 3:30 p.m.
Understanding the Impact of Hypophosphatasia (HPP) on Health-Related Quality-of-Life and Activities of Daily Living: A Patient-Based Conceptual Model
Poster Presentation #011
Sunday, Oct. 11, 2 – 3:30 p.m.
Prospective, Observational Study of a Cohort of Hypophosphatasia Patients' Phenotypes Over Time and the Utility of Digital Outcomes Measures in This Population
Poster Presentation #521
Sunday, Oct. 11, 2 – 3:30 p.m.
ENPP1 Inhibition Improves the Bone Phenotype, Mobility, Muscle Strength and Endurance in Later-Onset HPP Mice
Oral Presentation #1139
Monday, Oct. 12, 11:42 – 11:54 a.m.
About Achondroplasia
Achondroplasia, the most common form of skeletal dysplasia leading to disproportionate short stature in humans, is characterized by slowing of endochondral ossification, which results in disproportionate short stature and disordered architecture in the long bones, spine, face and base of the skull. This condition is caused by a change in the FGFR3 gene, a negative regulator of bone growth.
More than 80% of children with achondroplasia have parents of average stature and have the condition as the result of a spontaneous gene mutation. The worldwide incidence rate of achondroplasia is about one in 25,000 live births. VOXZOGO is being tested in children whose growth plates are still "open," typically those under 18 years of age. Approximately 25% of people with achondroplasia fall into this category.
For more information about our clinical trials in achondroplasia, hypochondroplasia and other skeletal conditions, please visit clinicaltrials.biomarin.com.
About Hypochondroplasia
Hypochondroplasia is a rare, genetic skeletal dysplasia characterized by impaired bone growth, leading to disproportionate short stature and skeletal differences that can affect the long bones, spine and other parts of the skeleton and may impact physical functioning and overall quality of life. The condition presents with a broad and variable clinical spectrum and may include otolaryngologic (related to the ears, nose and throat) and neurological complications and is often diagnosed in toddlerhood or early school age based on clinical and radiological findings. BioMarin estimates that roughly 14,000 children with hypochondroplasia within the company's global footprint may be eligible for treatment with VOXZOGO.
There are currently no medicines approved by the U.S. Food and Drug Administration or the European Medicines Agency for the treatment of hypochondroplasia.
For more information about our clinical trials in hypochondroplasia, achondroplasia and other skeletal conditions, please visit clinicaltrials.biomarin.com.
About VOXZOGO
In children with achondroplasia, endochondral bone growth, an essential process by which bone tissue is created, is negatively regulated due to a gain of function mutation in FGFR3. VOXZOGO, a C-type natriuretic peptide (CNP) analog, acts as a positive regulator of the signaling pathway downstream of FGFR3 to promote endochondral bone growth.
VOXZOGO is the only approved medicine to support the growth of children with achondroplasia starting from birth, with international consensus guidelines recommending initiation of VOXZOGO as early as possible. First approved in 2021, VOXZOGO has helped more than 5,000 infants and children in more than 50 countries. Through our ongoing studies, BioMarin continues to evaluate VOXZOGO on key clinical endpoints relevant for achondroplasia patients, such as arm span, tibial bowing (leg bowing), body proportionality, spinal morphology (including spinal stenosis) and quality of life measures.
VOXZOGO is approved in the U.S., Japan and Australia to increase linear growth in children of all ages with achondroplasia with open epiphyses, and VOXZOGO is indicated in the EU for the treatment of achondroplasia in children 4 months of age and older whose epiphyses are not closed, as confirmed by appropriate genetic testing. In the U.S., this indication is approved under accelerated approval based on an improvement in annualized growth velocity. Continued approval may be contingent upon verification and description of clinical benefit in confirmatory trial(s). An sNDA with long-term safety and efficacy data from three ongoing studies, including adult height and additional clinical outcomes beyond linear growth such as body proportionality and arm span, is under review with an FDA Prescription Drug User Fee Act (PDUFA) target action date of Feb. 28, 2027.
The use of VOXZOGO to treat hypochondroplasia has not yet been approved by any regulatory agency.
Patient Support Accessing VOXZOGO
BioMarin's robust support services have ensured a seamless treatment experience, spearheaded by Clinical Coordinators, who have conducted hundreds of trainings for families with achondroplasia since approval. BioMarin provides resources to support families navigating achondroplasia, including a caregiver mentorship program that connects parents with other caregivers, and a U.S. doctor directory that helps families and healthcare professionals identify clinicians experienced in achondroplasia care.
To reach a BioMarin RareConnections® Case Manager, please call, toll-free, 1-833-VOXZOGO (1-833-869-9646) or email [email protected]. For more information about VOXZOGO, please visit www.voxzogo.com. For additional information regarding this product, please contact BioMarin Medical Information at [email protected].
VOXZOGO U.S. Important Safety Information
What is VOXZOGO used for?
VOXZOGO is a prescription medicine used to increase linear growth in children with achondroplasia and open growth plates (epiphyses). VOXZOGO is approved under accelerated approval based on an improvement in annualized growth velocity. Continued approval may be contingent upon verification and description of clinical benefit in confirmatory trials. What is the most important safety information about VOXZOGO?
VOXZOGO may cause serious side effects including a temporary decrease in blood pressure in some patients. To reduce the risk of a decrease in blood pressure and associated symptoms (dizziness, feeling tired, or nausea), patients should eat a meal and drink 8 to 10 ounces of fluid within 1 hour before receiving VOXZOGO. What are the most common side effects of VOXZOGO?
The most common side effects of VOXZOGO include injection site reactions (including redness, itching, swelling, bruising, rash, hives, and injection site pain), high levels of blood alkaline phosphatase shown in blood tests, vomiting, joint pain, decreased blood pressure, and stomachache. These are not all the possible side effects of VOXZOGO. Ask your healthcare provider for medical advice about side effects, and about any side effects that bother the patient or that do not go away. How is VOXZOGO taken?
VOXZOGO is taken daily as an injection given under the skin, administered by a caregiver after a healthcare provider determines the caregiver is able to administer VOXZOGO. Do not try to inject VOXZOGO until you have been shown the right way by your healthcare provider. VOXZOGO is supplied with Instructions for Use that describe the steps for preparing, injecting, and disposing VOXZOGO. Caregivers should review the Instructions for Use for guidance and any time they receive a refill of VOXZOGO in case any changes have been made. Inject VOXZOGO 1 time every day, at about the same time each day. If a dose of VOXZOGO is missed, it can be given within 12 hours from the missed dose. After 12 hours, skip the missed dose and administer the next daily dose as usual. The dose of VOXZOGO is based on body weight. Your healthcare provider will adjust the dose based on changes in weight following regular check-ups. Your healthcare provider will monitor the patient's growth and tell you when to stop taking VOXZOGO if they determine the patient is no longer able to grow. Stop administering VOXZOGO if instructed by your healthcare provider. What should you tell the doctor before or during taking VOXZOGO?
Tell your doctor about all of the patient's medical conditions including If the patient has heart disease (cardiac or vascular disease), or if the patient is on blood pressure medicine (anti-hypertensive medicine). If the patient has kidney problems or renal impairment. If the patient is pregnant or plans to become pregnant. It is not known if VOXZOGO will harm the unborn baby. If the patient is breastfeeding or plans to breastfeed. It is not known if VOXZOGO passes into breast milk. Tell your doctor about all of the medicines the patient takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements. You may report side effects to BioMarin at 1-866-906-6100. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see additional safety information in the full Prescribing Information and Patient Information.
About BioMarin
BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. To learn more, please visit www.biomarin.com.
Forward-Looking Statements
This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc. (BioMarin), including without limitation, statements about: the data to be presented at the American Society for Bone and Mineral Research 2026 Annual Meeting (ASBMR), including the potential impact and safety of VOXZOGO in children with achondroplasia and hypochondroplasia; BioMarin's plans and expectations for the development of VOXZOGO for children with hypochondroplasia, including plans for submissions to the European Medicines Agency (EMA) and other regional health authorities as well as the expectation that, if approved by the U.S. Food and Drug Administration (FDA), VOXZOGO would be the first targeted therapy for the treatment of hypochondroplasia with an anticipated launch in 2027; BioMarin's expectations regarding its supplemental New Drug Application (sNDA) for VOXZOGO for full approval in children with achondroplasia, including expectations regarding the Prescription Drug User Fee Act (PDUFA) target action date; BioMarin's plans and expectations for the development of BMN 333; and BioMarin's estimate regarding incidence and total addressable patient population (TAPP) with respect to the conditions targeted by BioMarin's product candidates and commercial products, including achondroplasia and hypochondroplasia. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others, results and timing of current and planned preclinical studies and clinical trials and the release of data from those trials; any potential adverse events observed in the continuing monitoring of the patients in the clinical trials; the content and timing of decisions by the FDA, the EMA, the European Commission and other regulatory authorities; and those factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, as such factors may be updated by any subsequent reports. Investors are urged not to place undue reliance on forward-looking statements, which speak only as of the date hereof. BioMarin is under no obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.
BioMarin®, BioMarin RareConnections® and VOXZOGO® are registered trademarks of BioMarin Pharmaceutical Inc.
President Donald Trump purchased up to $5 million in SpaceX (NASDAQ: SPCX) bonds just two days before signing a major order to accelerate the U.S. commercial space industry.
According to a disclosure released on October 8, Trump bought $1-5 million worth of senior unsecured SpaceX bonds on August 18, two days before signing a memorandum to usher in a “golden age” of American space transportation.
More precisely, the initiative seeks to expand launch and reentry activity on U.S. soil to more than 1,000 operations annually by 2030, partly by speeding up permitting procedures and environmental reviews. The securities themselves mature in July 2031 and carry an interest rate of 5.35%.
This is how much Trump is up on SpaceX stock SpaceX stock was trading at $160 at the press time, October 9, having gained nearly 12% since Trump made his purchase.
SpaceX stock price one-month chart. Source: Finbold Elon Musk’s space company, naturally, stands to benefit from the policies intended to reduce regulatory barriers for commercial space operators, so the timing behind Trump’s bond move has renewed concerns about potential conflicts of interest.
However, the White House has maintained in the past that Trump does not personally direct his investment decisions, with his stock and bond portfolio independently managed by third-party financial institutions through discretionary accounts.
The SpaceX transaction was also just one of more than 500 trades the president made in August, according to the same disclosures. Other notable moves included up to $25 million in Meta (NASDAQ: META) and up to $6 million in Microsoft (NASDAQ: MSFT) stock.
Overall, while the filings indeed do not pove that Trump’s bond purchase influenced the administration’s space policy, the timing has nonetheless intensified scrutiny of how the president’s portfolio is managed while his administration makes decisions that could affect companies in which he invests.
Featured image via Shutterstock
Best Crypto Exchange for Intermediate Traders and Investors
Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.
0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.
Copy top-performing traders in real time, automatically.
eToro USA is registered with FINRA for securities trading.
30+ million Users worldwide
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD
Join Finbold's newsroom, become a Sales Executive today! Apply now to join Finbold as a crypto/finance news writer!
UBS varuje před slábnoucí poptávkou po modelu iPhone 18 Pro: průměrná čekací doba se během týdne zkrátila o šest dní, zatímco nabídka zůstala stabilní.
Apple Inc (NASDAQ:AAPL, XETRA:APC) faces growing iPhone 18 Pro demand concerns as delivery waits shorten, with UBS retaining a ‘neutral’ rating and $296 price target.
UBS Evidence Lab data covering more than 30 geographies showed average iPhone 18 Pro wait times shortened by about six days over the week.
The broker said falling waits against stable supply were increasingly concerning, particularly after price rises heightened the risk that customers would become more sensitive to cost.
However, Pro Max wait times remained relatively steady over the week, averaging about 24 days, down from 25 days for the previous model a year earlier.
These mixed signals precede the start of preorders for the $1,999 iPhone Duo on 16 October 2026, with availability following on 23 October.
UBS expects the Duo to draw demand from high-end Pro Max devices, leaving Pro Max waits flat to slightly lower the following week versus the previous model a year earlier.
Despite its concerns, UBS left iPhone estimates unchanged, forecasting September 2026 quarter revenue of $55.9 billion, up 14.0%, against management guidance for mid-teens growth.
Its forecast of 55.0 million iPhones for the quarter, up 2.8%, remains below consensus of 57.8 million units.
For the 2026 financial year, UBS expects iPhone revenue of $252.4 billion, up 20.4%, compared with consensus of $252.2 billion.
The broker’s valuation balances solid iPhone demand against mounting gross-margin pressure and supply-chain challenges.
Meta očekává, že její kapitálové výdaje v roce 2026 dosáhnou 130 až 145 miliard USD, zatímco volné peněžní toky ve 2. čtvrtletí klesly na 784 milionů USD.
Meta is spending more on AI than almost any company on earth, and that bet could either supercharge your monthly contributions or drag them down. Here is what four years of disciplined investing actually looks like across the bull, base,…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Putting $500 a month into Meta Platforms (NASDAQ:META | META Price Prediction) builds a position in one of the market’s biggest AI spenders without needing to pick a perfect entry point.
Shares traded at $733.35 in premarket action, slightly below the $738.88 close our price model uses as its starting point. Below is what that monthly contribution could be worth by 2030 and at the model’s full five-year horizon.
What $500 a Month Could Become by 2030 In the base case, four years of contributions ($24,000 invested) could be worth about $31,733.51 by 2030. That means you would gain 32.22% on the money you put in. Treat the 2030 figure as illustrative, because 2030 falls between the model’s 1-year and 5-year horizons.
Tied to the projected five-year horizon (2031-10-07), 60 contributions totaling $30,000 could reach about $42,629.06, a 42.10% gain. Behind that number is a base-case share price of $1,423.93, for a 92.71% total return (14.02% annualized). Your monthly plan makes less than a lump sum would because the later deposits have less time to grow.
The math assumes each $500 goes in at the start of the month and grows at each scenario’s projected annualized return. It leaves out dividends, taxes and fees.
Bull, Base and Bear Scenarios for Your Monthly Stake Scenario 5-Year Target Price Share Price Total Return $500/Month Value at 5 Years Illustrative 2030 Value Bull $1,722.16 133.08% $47,512.35 (58.37%) $34,556.35 (43.98%) Base $1,423.93 92.71% $42,629.06 (42.10%) $31,733.51 (32.22%) Bear $945.92 28.02% $34,096.47 (13.65%) $26,587.91 (10.78%) Over the shorter term, the model’s 1-year base target is $923.03, or 24.92% upside, inside a range of $786.35 to $1,061.42. The model’s confidence score is 0.9 on a 0 to 1 scale.
Wall Street’s consensus target is lower, at $794.96, based on 8 Strong Buy, 47 Buy, 7 Hold and 1 Sell ratings.
Three Forces Behind Meta’s Price Path AI is lifting the ad business. Second-quarter revenue reached $60.8 billion, up 28% year over year. Ad impressions rose 14% and the average price per ad rose 12%. Meta is selling more ads and charging more for each one. Its Advantage Plus tools, which automate ad campaigns, passed an annual revenue run rate of $75 billion.
New revenue lines are forming. After Meta integrated Muse Spark, its AI model, the number of people using Meta AI each day rose 60%. More than 1 million businesses now use Meta’s business agents every week. Wells Fargo argued that Muse can soar much higher, and MarketWatch reported a rare “golden cross” buy signal as users turn to Meta’s AI agent.
On the earnings call, the CEO said “AI is accelerating our core business today, powering our next generation of products, and opening the door to entirely new enterprise opportunities.”
The valuation leaves room to grow. The model uses forward EPS of $31.636 and a forward P/E of 23x, along with a consensus growth rate of 0.1961. For a company with operating margins of 41.44%, that is a reasonable starting multiple.
What Could Derail Your $500-a-Month Plan Spending is the biggest risk. Meta expects 2026 capital expenditures of $130 to $145 billion, and second-quarter free cash flow fell to $784 million. Q2 EPS of $6.18 missed the $7.10 estimate, weighed down by $2.4 billion in legal charges and $1.2 billion in severance costs.
That capex has to be spent somewhere, which is why we featured seven power, cooling and networking suppliers riding the same expansion in a free AI infrastructure report.
Other risks remain. Meta faces several youth-related trials in the U.S. that could lead to material losses, and EU regulators are pressing it on ads. Reality Labs lost about $19.2 billion in 2025.
The stock is also volatile, with a beta of 1.185, and it has grown only 2.8% over the past year despite strong revenue growth. If AI returns come in slower than hoped, the downside gain of 13.65% on your contributions becomes the more realistic outcome.
Where Your Monthly Contributions Could Land By 2030, $500 a month in Meta could be worth anywhere from $26,587.91 to $34,556.35 in this illustrative view. At the full five-year horizon, the range is $34,096.47 to $47,512.35.
These numbers depend on Meta’s AI spending paying off, so watch free cash flow and capex guidance in each earnings report. This is a projection rather than a recommendation, and none of these outcomes is guaranteed.
Contact [email protected] for any questions or corrections.
Tesla získala od společnosti IMC Logistics objednávku na 50 elektrických tahačů Tesla Semi. Nový závod v Nevadě má výrobní kapacitu až 50 000 vozidel ročně.
Key Takeaways TSLA secured an order for 50 Semi trucks from IMC Logistics, expanding its heavy-duty trucking presence. Tesla's lead-supplier role in a 2,500-truck alliance could boost its order pipeline and production scale-up. TSLA's new 1.7-million-square-foot Nevada factory is designed to produce up to 50,000 trucks annually. Per Teslarati, Tesla, Inc. (TSLA - Free Report) has secured an order for 50 all-electric Semi trucks from IMC Logistics, expanding its presence in the heavy-duty trucking market. The deal adds to growing commercial interest in Tesla’s electric trucks as the company ramps up production and diversifies beyond passenger vehicles.
The order follows Einride’s planned deployment of 500 Tesla Semis, WattEV’s order for 370 trucks and the ZET SCALE alliance’s initial order for 2,500 electric Class 8 trucks, with Tesla selected as the primary manufacturer. Tesla leads but doesn't have the deal to itself. PACCAR’s (PCAR - Free Report) Kenworth, and Volvo Group’s (VLVLY - Free Report) Volvo are also on the supplier list.
According to FreightWaves, the alliance, backed by shippers including Microsoft and PepsiCo, aims to expand its program to at least 10,000 trucks. While the 2,500-truck order is shared across manufacturers, Tesla’s lead-supplier position could strengthen its order pipeline, support production scale-up and accelerate adoption of its zero-emission Semi.
FreightWaves further reports that IMC will deploy the trucks for port drayage and freight routes connecting Southern California with inland destinations. These commitments could improve Tesla’s order visibility, support factory utilization and help spread manufacturing costs across higher production volumes. The Semi’s zero-tailpipe-emission operation strengthens its appeal to fleet operators seeking to reduce transportation emissions and meet environmental requirements.
The IMC deal allows Tesla to demonstrate the Semi’s commercial performance and attract more fleet customers, although the 50-truck order is unlikely to materially affect near-term revenue. Longer-term growth will depend on delivery execution, cost control and competitive operating economics, potentially establishing the Semi as an additional revenue driver beyond passenger vehicles.
Notably, Tesla’s new Semi factory in Nevada opened in the last week of September. Located beside the 4680 battery cell lines at Gigafactory Nevada, the 1.7-million-square-foot facility is built to produce up to 50,000 trucks a year
Tesla faces competition from established manufacturers expanding their battery-electric truck offerings. Volvo’s VNR Electric, designed for regional hauling and distribution, offers a range of up to 275 miles. PCAR’s Kenworth T680E and Peterbilt 579EV also target regional haul and port drayage, with advertised ranges of more than 200 miles and up to 200 miles, respectively, depending on configuration. These models give fleet operators alternatives to Tesla’s Semi as they seek to reduce emissions and operating costs. Tesla’s ability to demonstrate reliable performance, competitive operating costs and timely deliveries will be important to winning orders and expanding its presence in the electric heavy-duty truck market.
The Zacks Rundown for TeslaShares of TSLA are down 9.4% in a year compared with its industry's 2.8% rise.
Image Source: Zacks Investment Research
Tesla is currently trading at a forward 12-month price-to-sales of 12.87X, higher than the industry’s average of 3.35X. It carries a Value Score of D.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for TSLA for 2026 earnings implies year-over-year growth of 6%.
Image Source: Zacks Investment Research
The consensus estimate for EPS for fiscal 2026 has been flat over the past 60 days.
Image Source: Zacks Investment Research
TSLA currently has a Zacks Rank of #4 (Sell).
You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Key Takeaways TSLA could gain Slovakia's approval for FSD, potentially marking its ninth EU market for the technology.Data indicating lower accident rates back Slovakia's decision, but drivers remain responsible for vehicles.Wider FSD adoption could boost paid subscriptions and advance autonomous-driving plans. Per Reuters, Slovakia is expected to approve Tesla’s (TSLA - Free Report) Full Self-Driving (FSD) system, potentially becoming the ninth European Union (“EU”) country to authorize the driver-assistance technology. Per Reuters, Transport Minister Jozef Raz indicated that Slovakia would formally communicate its decision to the Netherlands, where the vehicle regulator, RDW, had cleared Tesla’s system earlier this year and acts as the primary regulatory authority for the automaker’s FSD technology in Europe.
He also added the decision was supported by data indicating lower accident rates, while emphasizing that drivers would remain responsible for their vehicles. Once the letter is delivered, FSD would become available for use in Slovakia.
The expected approval adds to Tesla’s progress in expanding FSD availability across Europe, following authorizations in countries including Belgium, Croatia, the Czech Republic, Slovenia, the Netherlands, Denmark, Estonia and Denmark. The development comes as Tesla continues to push for wider regulatory acceptance of its technology, with efforts to persuade European regulators to approve FSD. An EU-wide vote could take place as soon as December, potentially opening the door to broader deployment across the region.
From Tesla’s perspective, wider FSD adoption could support software monetization through paid subscriptions and enhance the value proposition of its vehicles. The system assists with steering, speed and navigation in various driving situations.
Additional country-level approvals could help Tesla expand its addressable customer base, gather more real-world driving data and advance its longer-term autonomous-driving strategy. However, further growth will depend on regulatory decisions, demonstrated safety and customer adoption.
As competition in advanced driver-assistance technology intensifies, Tesla faces challenges from automakers developing comparable systems. General Motors’ (GM - Free Report) Super Cruise offers hands-free driving on compatible roads, automatic lane changes and driver-monitoring technology across multiple models. GM is also developing eyes-off driving capabilities for select Cadillac models. Rivian Automotive’s (RIVN - Free Report) Autonomy+ provides hands-free, eyes-on driving across more than 3.5 million miles of roads in the United States and Canada, with features including lane-position adjustments and driver-initiated lane changes.
Tesla’s expected expansion into additional European markets could broaden FSD adoption and support software revenue growth. However, sustaining its competitive position will depend on securing regulatory approvals, demonstrating safety and offering compelling pricing. Continued software enhancements and greater paid subscription adoption could help Tesla differentiate its technology and strengthen recurring revenue.
The Zacks Rundown for Tesla Shares of TSLA are down 9.4% in a year against its industry's 2.8% rise.
Image Source: Zacks Investment Research
Tesla is currently trading at a forward 12-month price-to-sales of 12.87X, higher than the industry’s average of 3.35X. It carries a Value Score of D.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for TSLA for 2026 earnings implies year-over-year growth of 6%.
Image Source: Zacks Investment Research
The consensus estimate for EPS for fiscal 2026 has been flat over the past 60 days.
Image Source: Zacks Investment Research
TSLA currently has a Zacks Rank of #4 (Sell).
You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Amazon.com Inc. (NASDAQ:AMZN) stock rose nearly 1% during Friday’s premarket session as broader market sentiment improved. Nasdaq futures gained 0.72%, while S&P 500 futures climbed 0.37%, signaling stronger investor appetite for risk.
The gains come as the company expands across e-commerce, cloud computing, and artificial intelligence. Investors are also weighing which businesses could drive its next phase of earnings growth.
Analyst Sees Amazon Stock As UndervaluedNeedham analyst Laura Martin sees Amazon stock as undervalued, citing its customer ecosystem, growing AI adoption and higher-margin cloud operations.
Martin told CNBC on Thursday that only about 20% of Amazon’s traffic is exposed to outside AI-driven commerce tools because most shoppers go directly to Amazon’s website or app.
She also said 67% of Amazon users now use AI when searching for products on the platform.
AI Infrastructure Gives Amazon a Competitive EdgeMartin believes generative AI will favor the largest technology companies because they have stronger infrastructure, deeper technology resources and greater control over their ecosystems.
Martin contrasted Amazon with Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL) Google and Meta Platforms Inc. (NASDAQ:META), saying those companies historically operated with lighter capital requirements but are now spending more heavily on infrastructure.
Amazon, by comparison, has long invested heavily in physical assets and data centers, which Martin views as a core strength.
She said that experience could help Amazon as AI demand increases and large technology companies spend more on computing capacity.
Cloud Growth and Higher Margins Drive Earnings PotentialMartin said Amazon has effectively become a cloud company, with its cloud business growing 40% at roughly 35% margins.
By contrast, she said e-commerce operates at about 1% margins and requires heavy investment, even though it helps fund Amazon’s broader operations.
Martin said Amazon can turn physical infrastructure into much higher-margin cloud revenue, improving its earnings power compared with the lower-margin retail business.
The stock carries a consensus Buy rating, with an average analyst price forecast of $335 across 50 analysts. Forecasts range from $250 to $400. Recent analyst actions include:
Tigress Financial: Raised its price forecast to $385 from a previous level on Oct. 6, maintaining a Buy rating. TD Cowen: Maintained its Buy rating and $350 price forecast on Oct. 5. Rosenblatt: Raised its price forecast to $360 on Sept. 30, maintaining a Buy rating. AMZN Price Action: Amazon.com shares were up 0.77% at $256.00 during premarket trading on Friday, according to Benzinga Pro data.
GitHub je přibližně ze 60 % migrován na Azure, aby vyřešil kapacitní problémy po nárůstu využívání AI agentů; v září zaznamenal 7,38 miliardy potvrzení změn.
GitHub COO Kyle Daigle, who now also leads developer marketing for all of Microsoft, speaks at GitHub Universe last year. (Microsoft Photo) GeekWire is profiling over the next few weeks some of the people and teams that are shaping the evolution of Microsoft in what we’re calling its “Microsoft 2.5” era.
A delicate dance: In August 2025, Microsoft moved to integrate GitHub into the mothership, under its CoreAI division, after having allowed it to run as a quasi-independent entity since acquiring it in 2018. At the same time, GitHub CEO Thomas Dohmke announced he would leave the company at the end of the year.
A number of developers feared the worst: GitHub would become just another arm of Microsoft and lose the community-mindedness that had made it attractive to developers of all stripes, and especially open-source ones.
GitHub Chief Operating Officer Kyle Daigle — a 13-plus-year GitHub veteran — had been one of the main champions of the need to “keep GitHub GitHub.” He maintained that stance even after he added the “Chief Marketing Officer of Developer” title for all of Microsoft to his COO role in January 2026.
So, how has Microsoft done this past year with managing GitHub? In an interview with GeekWire, Daigle acknowledged that GitHub’s relationship with Microsoft has changed since the end of the standalone CEO era. But the goal is no longer just “don’t break GitHub.” It’s to export GitHub’s community, developer-first ethos and learnings across Microsoft.
GitHub has influence beyond just the GitHub product set now, Daigle said. And the fact that Microsoft opted to consolidate its developer-facing messaging and community outreach under Daigle, someone who came from GitHub, not from Microsoft’s traditional DevDiv organization, gives weight to his claim.
“Bringing teams together — engineering teams and marketing teams and everyone that wasn’t talking to each other before — has been a really big part of the work,” Daigle said. “I see all these opportunities for GitHub to directly help and impact the overall mission of Microsoft versus keeping it cloistered in a way that isn’t helping either GitHub’s mission or Microsoft’s mission.”
These days, developer teams across Microsoft and GitHub are sharing foundations and the GitHub Copilot software development kit across organizations “in a way that would have seemed improbable before,” he said.
As Microsoft historians know, “Microsoft’s challenge isn’t creating products. It’s connecting them,” Daigle said.
Growing pains: At the same time, the rise of AI agents has strained GitHub’s infrastructure. Over the past few months, GitHub has experienced some significant outages, including one in August that lasted nearly eight hours.
GitHub officials have said they are migrating from their own datacenters to Azure to try to ease some of the capacity issues. Daigle said it’s not a simple lift-and-shift process; rather, it’s a major re-architecture for the platform.
GitHub is roughly 60% through its Azure migration as of early October, he said.
It’s working with Azure storage teams on separating compute and storage for the Git distributed version control system to help alleviate bottlenecks caused by developers and agents working concurrently in the same repositories. Developers and agents made 7.38 billion commits on GitHub in September alone, according to the company.
GitHub’s recent growth would not have been manageable without Microsoft scaling expertise and Azure support, Daigle said. GitHub is in a unique position of being able to request major additional capacity, such as millions of CPUs, and work with Microsoft teams to provision it, he said.
The GitHub app and agent store: GitHub got its start as a platform for source control and collaboration. But its role is evolving as part of its Microsoft integration. In addition to developing and supporting Microsoft’s most successful Copilot, GitHub Copilot, GitHub has an important place in Microsoft’s agent-centric strategy.
GitHub is becoming “the store for anything that needs to be coded and needs some verification,” Daigle said. “We’ll connect you to whatever the right tool inside of Microsoft is for you to run that or whatever tool you’re using, not just (from) the Microsoft product suite.”
In the new world order, GitHub isn’t just the store for apps. Increasingly, it’s also the store for agents, which means GitHub is acting as the developer layer for Microsoft’s “agent factory” strategy.
(Microsoft co-founder Bill Gates envisioned Microsoft as a “software factory” that could produce software at scale. These days, CEO Satya Nadella and team talk about Microsoft as an “agent factory,” helping customers create agents at scale.)
GitHub currently serves more than 200 million developers, plus an unknown but quickly growing number of agents.
Developers need to be thinking in new ways when it comes to agents, Daigle said. They need to consider ideas such as scaling application programming interfaces (APIs) for agents separately from humans, creating APIs designed specifically for agents, rewriting documentation and tooling so agents can consume GitHub efficiently, and treating agent access as a fundamentally different workload from human access.
In the longer term, Daigle said he expects AI to make software economically viable for smaller audiences, such as a family, an individual or a single team. The app-store model may change substantially in the coming years, as people create highly specialized applications. GitHub could help like-minded users discover software for specific interests, such as a narrowly focused household or community use case.
GitHub historically has considered anyone who has seen or touched code to be part of the developer community. Daigle’s vision is for GitHub and Microsoft to let both professional developers and newer builders create and run software and agents without needing to manage token costs, uptime, monitoring or operational overhead.
GitHub will have more to say about its plans at the GitHub Universe conference in San Francisco, Oct. 28-29. The event won’t focus on code generation alone; it will include information on tools covering the full lifecycle, proactive security approaches and how to determine whether software is working well after deployment.
“We’re looking to solve the core parts of the platform, like Git, like Actions, in a way that I hope will make people excited and feel like they can absolutely trust GitHub for the next decade to come,” Daigle said.
A $10,000 bet on AMD in 2011 grew into more than $1.2 million, but the AI boom that sent shares soaring 211% in a single year raises a harder question: how much runway is left in a stock already priced…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Someone who put $10,000 into Advanced Micro Devices (NASDAQ:AMD | AMD Price Prediction) at the end of 2011, when shares closed at $5.40, would have about $1,202,629 at the most recent close of $649.42.
The last 10 years alone produced a 9,314.81% gain, enough to turn $10,000 into $941,481. AMD now trades at $656.10, and the AI data center buildout is the main story behind it. So what could $10,000 invested today be worth by 2031?
What $10,000 Could Become by 2031 In the base case, a $10,000 investment in AMD could be worth about $10,129 by 2031, a total return of 1.29%. That rests on a projected five-year share price target of $664.58, which works out to an annualized return of just 0.26%. The model’s confidence level is 0.9, which it rates as high.
The modest target shows how much good news is already in the price. Shares are up 211.96% over the past year and 196.74% so far this year. The stock also trades at 53x forward earnings.
The model’s forward P/E valuation comes out to just $458.27 per share, and that input gets the biggest weight in the average. On top of that, the model notes “slight overvaluation (-5.2%)” at today’s price.
Bull, Base and Bear Scenarios for Your $10,000 Scenario (2031) Target Price Total Return $10,000 Becomes Bull $826.94 26.04% $12,604 Base $664.58 1.29% $10,129 Bear $451.19 -31.23% $6,877 Over one year (to 2027), the model projects a narrower range. The bull case is $692.43 (5.54%, or $10,554). The base case is $622.15 (-5.17%, or $9,483). The bear case is $486.32 (-25.88%, or $7,412).
Wall Street sits close to the model. The consensus price target is $629.21, with 5 Strong Buy, 39 Buy and 11 Hold ratings and no Sells. Analysts are bullish on the business, but their average target is still below the current share price.
Growth Drivers That Could Push AMD Toward the Bull Case Data Center Revenue Is Accelerating Second-quarter revenue rose 50.1% to $11.54 billion, and Data Center revenue jumped 107% to $6.72 billion. Third-quarter guidance calls for about $13 billion in revenue. Management said it “now expect[s] data center segment revenue to more than double year-over-year in 2027.”
Gigawatt-Scale AI Customers OpenAI has a preferred-partner deal covering 6 GW of AMD GPUs. Anthropic plans to deploy up to two gigawatts of MI450 GPUs in AMD’s Helios racks. Helios begins shipping in the third quarter of 2026, and the chief executive said customer demand is “tracking ahead of our initial forecasts.”
Earnings Estimates Keep Climbing The consensus EPS estimate for 2027 has risen to $15.5833, up from $13.1770 90 days ago. AMD also says it expects to significantly exceed its $20 annual EPS target within its strategic period. If the company delivers on that, today’s valuation would look much cheaper, and the bull case becomes more realistic.
Risks That Could Shrink Your Stake With a beta of 2.454, AMD tends to move about 2.5 times as much as the overall market, in both directions. Under the five-year bear case, $10,000 drops to $6,877. Several things could get it there:
Export controls: Restrictions on MI308 sales to China cost AMD about $440 million in charges in fiscal 2025. Competition: NVIDIA (NASDAQ:NVDA) still leads the AI accelerator market. Supply and execution: AMD depends on Taiwan Semiconductor Manufacturing (NYSE:TSM) to make its chips and has to secure enough HBM memory, and management expects Helios yields to improve only over the next few quarters. Weak spots: Gaming revenue fell 31%, and a small number of very large AI customers account for much of the growth. Wide estimate range: Analyst EPS forecasts for 2027 run from $9.60 to $20.25. Can AMD Repeat Its Million-Dollar Run? The model doesn’t see a repeat. By 2031, it puts a $10,000 AMD stake anywhere from $6,877 in the bear case to $12,604 in the bull case, with a base case of $10,129.
AMD is now a company worth about $1.06 trillion, and growing from that size is far harder than growing from a $5 stock. These figures are model scenarios. The numbers to keep an eye on are Helios shipments and Data Center growth in 2027. This projection is for informational purposes only.
Contact [email protected] for any questions or corrections.
Avolon objednal 140 letadel Boeing a 110 letadel Airbus s opcí na dalších 100 letadel Airbus. Jde o jeho největší objednávku, která zvýší objednaný park společnosti na 749 strojů.
737 MAX airplanes sit on the final assembly production line during a media tour of the Boeing factory in Renton, Washington, U.S., April 15, 2026. REUTERS/Genna Martin/File Photo Purchase Licensing Rights, opens new tab
SummaryCompaniesLargest order Avolon has placed with either planemakerLessor's total aircraft on order rises to 749Offloads more older aircraft during the quarterDUBLIN, Oct 9 (Reuters) - Global leasing giant Avolon said on Friday it had agreed to order 140 aircraft from Boeing (BA.N), opens new tab and 110 from Airbus (AIR.PA), opens new tab, with an option to buy a further 100 jets from the European planemaker.
The orders were the largest Avolon, the world's third-biggest aircraft lessor, has placed with either manufacturer and bring its total number of aircraft on order to 749, on top of the 561 it currently owns.
Sign up here.
Dublin-based Avolon said the order comprised 140 Boeing 737 MAX jets, 75 Airbus A320neo planes and 35 of its wide-body A330neos, with options for a further 100 unspecified Airbus aircraft.
Aircraft lessors own around half the world's airline fleet and have been in hot demand from airlines in recent years due to a backlog of plane orders, a trend that has supported the specialist industry's rentals, resale values and profits.
It has also allowed leading lessors like Avolon to sell their older planes to make room for more fuel-efficient new-technology aircraft.
Avolon said in a trading update on Friday that it had sold 29 aircraft during the July-September quarter, with a further 112 aircraft agreed for sale at the end of September.
"We continue to see strong demand for new-technology aircraft, reflected in our placement and trading activity this quarter," Avolon CEO Andy Cronin said in a statement.
The new orders are subject to approval by Avolon's majority shareholder, China's Bohai Leasing Co Ltd (000415.SZ), opens new tab, which the lessor said is expected before the end of this month.
Adds details, CEO quotes throughout
Reporting by Padraic Halpin; editing by William James and Susan Fenton
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Boeing získal kontrakt v hodnotě 42,2 milionu USD na výrobu 29 konstrukcí senzorových sestav a výměnných sestav palivových nádrží pro program IRST Block II amerického námořnictva a australského letectva.
Key Takeaways Boeing won a $42.2M contract to produce IRST Block II assemblies for U.S. and Australian forces.Rising demand for passive sensing could support Boeing as militaries upgrade aircraft and detection systems.U.S. and allied investment in advanced situational awareness could sustain long-term IRST demand. The Boeing Company (BA - Free Report) is positioned to benefit from growing demand for advanced aircraft sensing technologies as the U.S. military and its allies seek better ways to detect and track increasingly sophisticated airborne threats. Infrared Search and Track (IRST) systems are gaining importance as they provide passive sensing capabilities that complement traditional radar systems.
IRST technology uses infrared sensors to detect and track aircraft and other objects without actively transmitting signals. This can help improve situational awareness and provide pilots with additional information in complex operating environments. The technology is particularly relevant as military forces focus on improving aircraft survivability and maintaining an advantage in contested airspace.
Boeing is supporting this trend through its work on the IRST Block II program for the U.S. Navy. In September, the company received a $42.2 million contract for the production of 29 sensor assembly structures and fuel tank assembly weapon-replaceable assemblies. The procurement includes units for the Navy and the Royal Australian Air Force, highlighting both domestic and allied demand.
The broader adoption of advanced sensing technologies could create opportunities for Boeing as military customers upgrade existing aircraft and develop next-generation capabilities. Demand for passive detection and tracking systems should remain important as threats become more difficult to identify and counter.
Boeing’s exposure to military aircraft and sensor programs, along with rising demand for advanced situational awareness, could support its defense business. Continued investment by the United States and allies should sustain long-term demand for technologies such as IRST.
Defense Stocks to Keep on the RadarGrowing demand for advanced aircraft sensors and threat-detection technologies could also benefit other defense contractors with strong sensor portfolios.
Lockheed Martin (LMT - Free Report) : Lockheed Martin develops advanced sensors and mission systems for fighter aircraft, including the F-35. Its sensor capabilities support pilots with enhanced detection, tracking and situational awareness.
Northrop Grumman (NOC - Free Report) : Northrop Grumman provides advanced radar, electronic warfare and sensor technologies for military aircraft. Its systems support threat detection and situational awareness across multiple defense platforms.
The Zacks Rundown for BAShares of Boeing have lost 8.4% in the past month compared with the Zacks aerospace-defense industry’s decline of 9.1%.
Image Source: Zacks Investment Research
From a valuation standpoint, BA is currently trading at a forward 12-month sales multiple of 1.36X, a discount when stacked up with the industry average of 2.07X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for BA’s 2026 and 2027 earnings has moved south over the past 60 days.
Image Source: Zacks Investment Research
BA stock currently carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Nike (NKE - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this athletic apparel maker have returned -5.1%, compared to the Zacks S&P 500 composite's +1.3% change. During this period, the Zacks Shoes and Retail Apparel industry, which Nike falls in, has lost 6.9%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
Nike is expected to post earnings of $0.40 per share for the current quarter, representing a year-over-year change of -24.5%. Over the last 30 days, the Zacks Consensus Estimate has changed -24.3%.
The consensus earnings estimate of $1.34 for the current fiscal year indicates a year-over-year change of -15.2%. This estimate has changed -25.6% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $1.78 indicates a change of +32.8% from what Nike is expected to report a year ago. Over the past month, the estimate has changed -23.9%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Nike is rated Zacks Rank #5 (Strong Sell).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
For Nike, the consensus sales estimate for the current quarter of $11.5 billion indicates a year-over-year change of -7.5%. For the current and next fiscal years, $42.72 billion and $44.89 billion estimates indicate -7.9% and +5.1% changes, respectively.
Last Reported Results and Surprise HistoryNike reported revenues of $11.21 billion in the last reported quarter, representing a year-over-year change of -4.3%. EPS of $0.48 for the same period compares with $0.49 a year ago.
Compared to the Zacks Consensus Estimate of $11.4 billion, the reported revenues represent a surprise of -1.65%. The EPS surprise was +11.63%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Nike is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Nike. However, its Zacks Rank #5 does suggest that it may underperform the broader market in the near term.
Nvidia se obchoduje za 230 USD, tedy 5,4 % pod letošním maximem, a to navzdory obavám z bubliny kolem AI. Tržby firmy přesáhly 104 mld. USD a pro příští rok očekává růst o více než 70 %.
Nvidia stock remained under pressure this week as prominent investors Ray Dalio and Michael Burry warned that an AI bubble could burst. Shares also fell after Firmus pulled its IPO and as investors reacted to recent reports on OpenAI’s revenue. The stock now trades at $230, about 5.4% below its high for the year.
Nvidia stock has retreated sharply as investors reacted to the ongoing crisis at Firmus, an Australian neocloud company that it has backed. The company decided to pull its IPO as investors balked at its hefty valuation.
Investors are also concerned about the ongoing weakness in companies like CoreWeave, Nebius, and IREN. Despite their strong revenue growth, these companies are losing millions of dollars and will need to raise more capital as the cost of data center buildup rise.
Meanwhile, investors are concerned about OpenAI, a company that Nvidia has invested billions of dollars in. A while ago, the company hinted that its revenue run rate was over $70 billion. Now, however, media reports suggest that the rate is about $20 billion below that level.
These numbers suggest that, while OpenAI is still growing, the trajectory is much lower than what analysts were expecting. As such, it might become more difficult for it to hit its valuation target after the Initial Public Offering (IPO).
There are also concerns about the artificial intelligence (AI) bubble. In a statement this week, Ray Dalio, the billionaire founder of Bridgewater Associates, said that the bubble will burst soon as US bond yields and interest rates rise.
Michael Burry, who is known for predicting the Global Financial Crisis, said that we are in the late stages of the AI bubble. He compared this to what happened in 2000 and 2008.
Despite the doom and gloom, all signs point to Nvidia’s business is doing well. The most recent results showed that Micron’s revenue soared by over 300% in the fourth quarter of its fiscal year. Similarly, Taiwan Semiconductor and Samsung Electronics published strong earnings, suggesting that companies in the technology sector are still spending.
Nvidia’s earnings were also strong, with its revenue soaring to over $104 billion. It also predicted that its annual revenue for next year will jump by over 70%. Nvidia tends to be highly conservative when making its guidance, meaning that its real figure will be higher.
The company’s guidance did not include its potential Chinese business because of the ongoing jitters with the US. There is a possibility that the company will see strong demand from Chinese companies over time. Also, it is likely that Nvidia underestimated the potential demand for its CPUs. In a statement this week, Microsoft said that the new laptops using the chip were the most powerful in its lineup.
Analysts have a bullish outlook for Nvidia shares. The average estimate is that its stock will rise to $321, up by nearly 40% from the current level. Some of the most bullish analysts are from companies like BNP Paribas, Cantor Fitzgerald, Rosenblatt Securities, Piper Sandler, Needham, and Philip Securities.
NVDA stock chart | Source: TradingView
Technical analysis suggests that the NVDA stock price peaked at $243 earlier this week and then retreated for the last three consecutive days. It has now moved below the support level of $236, its previous all-time high.
The stock has formed a rising wedge pattern, which is a common bearish reversal sign in technical analysis. Also, the Relative Strength Index (RSI) has continued falling. It is also below the Strong, Pivot, Reverse level of Murrey Math Lines. Therefore, the stock may drop further as sellers target the Strong, Pivot, Reverse level of Murrey Math Lines at $212.
Ředitel společnosti Nvidia Mark Stevens ve třetím čtvrtletí roku 2026 prodal 4 236 740 akcií za 946 627 633 USD, což je nejvíce ze všech amerických insiderů.
A longtime Nvidia director quietly converted a massive block of stock into cash just weeks before the company hit an all-time high, raising a question Jensen Huang's summer of silence makes harder to ignore.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Director Mark Stevens sold 4,236,740 shares of Nvidia (NASDAQ:NVDA | NVDA Price Prediction) in the third quarter of 2026 for $946,627,633. No other U.S. insider sold as much stock that quarter, and the ranking was published on October 7, 2026.
His last sale was on Sept. 18, 2026, several weeks before the ranking came out. Nvidia fell 2.94% to $230.48 on October 8, 2026. That drop came amid a broad selloff in artificial intelligence chip stocks, set off by concerns about OpenAI’s revenue.
A long-serving director turned a large block of stock into cash over about three weeks. During the same period, management forecast to $108.0 billion in third-quarter revenue and said demand was running ahead of supply. The filings look like a trim. The stake Stevens still owns, from a very large holding he has had since Nvidia’s venture-capital days, supports that view.
Three Rounds of Selling Ended in Mid-September From Aug 31 to Sept 2, 2026, Stevens sold 1,848,501 shares at about $220 to $226. He then sold 1,022,239 shares on Sept. 3 and 4 at $227.25 to $234.04, the highest prices of the three sales. The last round came on Sept. 18, when he sold 1,366,000 shares at about $219.40 to $220.42, the lowest prices of the three.
All sales went through a family trust. A trust holds assets for beneficiaries, so selling inside one often relates to estate planning, taxes, or family payouts. As a director, Stevens must report those sales.
His filings did not indicate a pre-arranged trading plan, unlike several others on the quarterly list, and a pre-arranged plan, known as a Rule 10b5-1 plan, sets the timing or size of future sales in advance.
What Stevens Still Owns Matters Most Stevens still holds about 27.5 million shares directly and through trusts. At the October 8 close, those shares were worth roughly $6.35 billion, so he has reduced his position while keeping most of it. He also sold about $407 million in June, bringing his total since early summer to roughly $1.35 billion.
His shares date back to Nvidia’s earliest years. He was a director from 1993 to 2006 and returned to the board in 2008. He was also a managing partner at Sequoia Capital, an early Nvidia investor.
He Outsold Every CEO on the List While Huang Sold Nothing Second on the list was Jayshree Ullal, chief executive of Arista Networks (NYSE:ANET), with $446.0 million. Michael Intrator, chief executive of CoreWeave (NASDAQ:CRWV), sold $347.2 million, and Jeff Bezos sold $346.5 million of Amazon (NASDAQ:AMZN).
Nvidia chief executive Jensen Huang made no open-market sales over the summer, and if insider trades signal conviction, Huang’s choice to hold while a director’s family trust sold deserves more weight.
Stevens also sold while the stock was near its highs. Nvidia set a record close of $239.24 on October 6, 2026, and the company was worth about $5.57 trillion at the October 8 close.
Why Nvidia’s Growth Outweighs These Insider Sales Nvidia’s fundamentals remain strong, and these filings don’t change that picture. Revenue for the fiscal second quarter was $96.221 billion, up 105.85% from a year earlier.
Management forecast third-quarter revenue of $108.0 billion, plus or minus 2%. It also said supply will remain a bottleneck at least through the end of fiscal year 2028. The stock trades at about 46 times earnings, a price-to-earnings ratio that this level of growth supports.
Two forecasts pose the biggest risks. Management expects business from AI labs that Nvidia helps finance to make up roughly a quarter of the company’s business next year, and it expects gross margins to bottom at 71% to 72% in the fourth quarter.
Two things could weaken the case for owning the stock. Third-quarter revenue in the next earnings report could come in below the $108.0 billion midpoint of guidance, or new Form 4 filings (the forms insiders file with the SEC to report trades) could show Huang selling on the open market. Until one of those happens, Stevens’ sales do not change the case for owning Nvidia.
Contact [email protected] for any questions or corrections.
Tržby společnosti Nvidia ve druhém čtvrtletí fiskálního roku 2027 meziročně vzrostly o 106 % na 96,2 miliardy USD, a to díky výdajům firem na infrastrukturu pro AI.
Nvidia (NVDA +0.29%) has been one of the biggest winners of the ongoing artificial intelligence (AI) revolution. That's why the company's shares have skyrocketed over the past five years. It's worth putting some numbers behind this to understand just how impressive Nvidia's performance has been since 2021. If you had invested $5,000 in the company then and held on, that investment would be worth about $58,045 today (including dividends reinvested). Of course, what matters now is how Nvidia might perform moving forward. Let's try to determine what a $5,000 investment today might be worth by 2031.
Image source: The Motley Fool.
Nvidia's tailwind isn't overThe AI boom is still very much in full swing. We got plenty of evidence for that claim during the latest earnings season. Many major tech (or tech-adjacent) corporations continue to spend significant sums on AI infrastructure, with some even increasing their capex guidance for the fiscal year 2026.
Alphabet (GOOG +1.30%) (GOOGL +1.16%) is one such example. Nvidia continues to benefit from the massive AI spending. During the company's second quarter of its fiscal year 2027, for the period ended July 26, revenue soared 106% year over year to $96.2 billion. Nvidia's non-GAAP operating income came in at almost $64 billion, up 124% year over year, while its non-GAAP earnings per share jumped 120% year over year to $2.22.
These are outstanding results for a company of this size, and they sent Nvidia stock up significantly post-earnings. There could be more where that came from. According to some estimates, AI infrastructure spending will exceed $1 trillion by 2029. For context, it was about $318 billion in 2025.
Of course, projections can be wrong. But there is tangible evidence, beyond companies' spending, that the AI industry could continue to grow at a good clip. Perhaps one sign is consumer adoption of the technology. Consider that in September, Meta Platforms (META -0.22%) launched what was perhaps one of the first mass-market, consumer-facing AI agents: Muse.
How did the public respond? Muse quickly rose to the top of the list of free iOS app downloads, racking up about 730,000 downloads in just five days. That at least suggests that there is a market for these kinds of products. But Meta had to spend significant sums on AI infrastructure to train advanced AI models and build AI agents on top of those models.
Premium Feature
Moneyball Superscore
95/100
Today's Change
(
0.29
%) $
0.67
Current Price
$
231.15
The lesson for other companies that want to launch consumer-facing AI agents is that it probably won't be cheap, and Nvidia's hardware, including its GPUs (graphics processing units) and CPUs (central processing units), can be an essential part of such a project. Nvidia's CEO, Jensen Huang, has predicted that there will eventually be billions of AI agents.
Perhaps that's too optimistic, but the rising prevalence of agents used within corporations and those used by individual consumers could be a powerful tailwind for the company in the medium term. Meanwhile, Nvidia still has major strengths, including a wide moat from switching costs, technological expertise, and deep relationships with many corporations, among others.
These advantages can allow the company to ride the AI tailwind over the next five years and overcome challenges such as competition.
Here's the mathEven though Nvidia still has massive opportunities, investors shouldn't expect the company to deliver the same returns through 2031 that it has over the past five years. But that's an incredibly high bar. The company could deliver highly competitive returns without matching its recent unreal performance.
Consider that Nvidia is currently trading at 24.9x forward earnings, compared to the 20.8x average for information technology stocks. And over the next five years, year-over-year earnings per share (EPS) growth should normalize. Assume EPS increases at an average of 15% over the next five years, and Nvidia's forward price-to-earnings drops to 22 by then.
The company would post annualized returns of roughly 12.2% over this period, turning $5,000 into about $8,885. Those are strong returns, and in my view, our assumptions are fairly defensible. Nvidia's EPS will likely grow much faster than 15% at least through the next several quarters.
All that to say: Nvidia remains in a good position to beat broader equities over the medium term. The company's shares are still a buy, despite some recent volatility.
Nvidia sits at $5.70 trillion today, but a specific calendar date, a single earnings report, and one supply-constrained growth target could determine whether it crosses a threshold no company has ever reached.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) has a path to close above a $10 trillion market capitalization by January 31, 2028, the last day of its fiscal 2028. This morning its market cap is $5.70 trillion, so the stock needs to gain 75.5%.
On 24,147,000,000 shares outstanding, that works out to about $414 per share. An early test comes with the Q3 fiscal 2027 earnings report, expected after the close on November 17, 2026. The company has not confirmed that date yet.
$10 Trillion Takes Only 26x Next Year’s Earnings The average analyst estimate for fiscal 2028 EPS is $15.6951, drawn from 53 analysts. A $414 share price works out to about 26x that figure. Today the stock trades at about 25x forward earnings, so the target needs NVIDIA to deliver earnings growth.
It needs almost no help from a higher multiple. Estimates are also rising: the fiscal 2028 consensus was $12.7102 90 days ago, and it has since rose 23.5%. Over the past 30 days, analysts made 42 up revisions and zero down ones.
Supply Caps Management’s 70% Growth Guidance Q2 revenue came in at $96.22 billion, up 105.8% year over year and ahead of the $92.07 billion estimate. Data Center revenue reached $89.02 billion. For fiscal 2028, management expects revenue growth of about 70% and called that outlook supply-constrained.
CEO Jensen Huang put it this way: “At this moment, we have supply for 70%. Our demand is much higher than that.” Q3 guidance is $108 billion ± 2%, and that figure includes no China Data Center compute revenue.
Vera Rubin Raises Revenue Per Gigawatt to $40 Billion NVIDIA earned about $18 billion per gigawatt with Hopper and $25 billion with Blackwell. With Vera Rubin, that figure rises to $40 billion. Management expects Vera Rubin to account for about 20% of Data Center revenue in Q3.
Existing and planned OpenAI commitments come to roughly 12 gigawatts of NVIDIA computing capacity. Spending is rising across the industry too: management expects the top five hyperscalers to spend nearly $800 billion on capital projects in 2026 and $1.3 trillion in 2027.
What to Watch on November 17 Revenue at or above the $108 billion guidance. Non-GAAP EPS compared with the $2.4733 consensus. The company has beaten estimates for 5 straight quarters. Gross margin within the forecast 74% ± 50bps. Management expects margins to bottom at 71% to 72% in Q4. Any update to the fiscal 2028 growth target of about 70%. Days sales outstanding, which rose to 60 days from 45, and supply obligations of $279 billion. If NVIDIA misses the January 31, 2028 deadline, the likely reasons are a supply chain already running flat out or memory costs eating into margins. Even so, analysts keep raising earnings estimates and demand still tops supply, so the $10 trillion target remains within reach.
Contact [email protected] for any questions or corrections.
Akcie AT&T v předobchodním obchodování klesly o více než 7 % poté, co SpaceX uzavřela dohodu o nákupu spektra, což posílilo obavy z konkurence ze strany Starlink Mobile.
Buy AT&T (T). The selloff is driven by fear that Starlink Mobile will replace traditional carriers, but AT&T’s fundamentals are steady: revenue up 2.3% QoQ, advanced connectivity revenue up 5.1% YoY, and low-single-digit service growth guidance. The chart also supports a rebound: it’s above the 100-week EMA and forming an inverted head-and-shoulders, with a likely move back toward $26.65 resistance.
Key Risk: SpaceX/Starlink actually wins enough US mobile customers fast enough to force AT&T to cut guidance and lose pricing power, not just create headlines.
Verizon (VZ) relative-value buy
Buy Verizon (VZ) versus the group. The article shows broad telecom dumping on the same SpaceX spectrum headline, but the market is likely overpricing near-term competitive impact. Verizon has similar “steady cash flow + dividends” appeal, so if the fear fades, VZ should rebound with less downside than the most fragile names. Use the same catalyst: selloff likely to mean-revert as FCC details and deployment realities (towers, limited spectrum) sink in.
Key Risk: Regulators or competitors accelerate spectrum/coverage plans in a way that makes Starlink’s competitive threat immediate and measurable in Verizon’s subscriber trends.
AT&T stock plunged by over 7% in the premarket session as investors dumped most telecommunications companies after SpaceX announced an agreement to purchase spectrum in the United States. It tumbled to $23, down by 13.3% from its highest point in September this year.
Other top telecommunications stocks have also tumbled. Verizon stock dropped by 5.1%, while T-Mobile fell by over 6.6%. The same trend is happening globally, with Deutsche Telekom, BT Group, and Vodafone falling by over 3%.
AT&T and other top telecom companies are in a steep freefall after SpaceX announced an agreement to purchase a nationwide spectrum portfolio from Gain Management, which specializes in digital infrastructure. In a statement, the company said:
“This prime low-band spectrum addresses one of the key remaining technical gaps that will pave the way for Starlink Mobile to become a major mobile carrier in the US.”
The concern among investors is that SpaceX, through its Starlink service, will become a major competitor to AT&T and other telecom companies. Still, history suggests that such disruption fears are often overstated.
Investors once worried that Amazon would upend retailers like Walmart and Target, and that traditional automakers would overtake Tesla in electric vehicles. Yet Walmart, Target, and Tesla all proved resilient.
Most notably, SpaceX faces some major challenges in urban areas as it will need to deploy towers on the ground. The new spectrum is also quite limited.
Focus now shifts to an upcoming vote by the FCC on a proposal to auction 25 megahertz of “prime spectrum” to support D2D services from satellites to smartphones. The vote will happen on October 29 and will benefit SpaceX and Amazon, which are building these solutions.
AT&T’s business is doing modestly well
The most recent results showed that AT&T’s business held steady in the second quarter. Its revenue rose by 2.3% in the quarter to $31.6 billion, with operating income rising to $7 billion.
The company added over 1 million advanced connectivity customers, which was driven by year-over-year increases in net adds across its fiber, fixed wireless and postpaid phone subscribers.
This growth brought its advanced connectivity services revenue to over $23.5 billion, up by 5.1% YoY. Most notably, its guidance was strong, with its service revenue is expected to grow by low single digits. It returned $4.1 billion to shareholders through dividends and buybacks, and plans to return $45 billion through 2028.
Analysts remain bullish on the stock. Scotiabank analysts have a target of $27.50, while Morgan Stanley, BNP Paribas, TD Cowen, and Argus suggest that it will jump to over $30.
T stock chart | Source: TradingView
The weekly chart shows that the AT&T share price slipped from a high of $26.64 in September to $23. A closer look shows that it has formed an inverted head-and-shoulders pattern, a common bullish reversal pattern.
The stock has remained slightly below the 23.6% Fibonacci Retracement level. It has moved above the 100-week Exponential Moving Average (EMA). Therefore, it is likely that the stock will bounce back as the SpaceX sell-off fades. Such a move may see it rebound to the key resistance level of $26.65.
A drone view shows the Netflix logo on one of the company's buildings in the Hollywood neighborhood in Los Angeles, California, U.S., January 20, 2026. REUTERS/Daniel Cole Purchase Licensing Rights, opens new tab
Oct 9 (Reuters) - Netflix (NFLX.O), opens new tab is planning to cut about 5% of its workforce, with an announcement expected as early as next week, Puck News reported on Friday, citing people familiar with the matter.
Netflix declined to comment on the report.
Sign up here.
The streaming giant's last major round of layoffs came in 2022, when the company cut hundreds of jobs amid slowing growth and subscriber losses
Netflix had about 16,000 full-time employees at the end of last year
The company is navigating an increasingly competitive streaming market, as media companies consolidate and YouTube captures a growing share of viewership and advertising spending
Netflix has been expanding beyond its subscription business, investing in advertising, live programming and gaming to diversify its revenue sources
Reporting by Harshita Mary Varghese in Bengaluru; Editing by Jonathan Ananda
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Walmart (WMT - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Over the past month, shares of this world's largest retailer have returned +4.6%, compared to the Zacks S&P 500 composite's +1.3% change. During this period, the Zacks Retail - Supermarkets industry, which Walmart falls in, has gained 4.3%. The key question now is: What could be the stock's future direction?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
Walmart is expected to post earnings of $0.63 per share for the current quarter, representing a year-over-year change of +1.6%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
For the current fiscal year, the consensus earnings estimate of $2.87 points to a change of +8.7% from the prior year. Over the last 30 days, this estimate has changed +0.1%.
For the next fiscal year, the consensus earnings estimate of $3.22 indicates a change of +12% from what Walmart is expected to report a year ago. Over the past month, the estimate has changed -0.2%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Walmart is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
For Walmart, the consensus sales estimate for the current quarter of $186.47 billion indicates a year-over-year change of +3.9%. For the current and next fiscal years, $751.39 billion and $783.33 billion estimates indicate +5.4% and +4.3% changes, respectively.
Last Reported Results and Surprise HistoryWalmart reported revenues of $187.94 billion in the last reported quarter, representing a year-over-year change of +5.9%. EPS of $0.81 for the same period compares with $0.68 a year ago.
Compared to the Zacks Consensus Estimate of $186.26 billion, the reported revenues represent a surprise of +0.9%. The EPS surprise was +10.96%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Walmart is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Walmart. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Jamie Dimon became the CEO of JPMorgan Chase (JPM +0.12%) on Jan. 1, 2006, and has now served as the company's top executive for more than two decades. While there was some talk earlier this year about the banking giant's succession plans, Dimon confirmed that he plans to remain CEO for at least several more years.
While the consumer banking, investment banking, and asset management industries have gone through some challenging periods over the last 20 years, the company has seen impressive success under Dimon's leadership and delivered returns that have substantially outstripped those of the S&P 500 (^GSPC +0.26%).
Dimon's leadership has helped power strong returns Since Jamie Dimon became JPMorgan's CEO, the company's stock has risen by roughly 730%. If you invested $10,000 in the company's stock on the day that he became the company's leader, your holdings would now be worth roughly $83,020. For comparison, the State Street SPDR S&P 500 ETF (SPY +0.25%) has risen roughly 524% over the same stretch -- and $10,000 invested in the exchange-traded fund (ETF) and held across the duration of Dimon's tenure would now be worth approximately $62,420.
JPMorgan's market-beating power becomes even more pronounced when dividends are factored into the equation. The bank has paid a dividend for 29 years running, issuing a direct cash payout to shareholders every year of Dimon's tenure, and currently has a 15-year streak of annual payout growth.
Premium Feature
Moneyball Superscore
74/100
Today's Change
(
0.12
%) $
0.40
Current Price
$
331.82
With dividends factored in, JPMorgan has delivered a total return of roughly 1,320% since Dimon became the company's CEO -- enough to turn a $10,000 investment held across the stretch into approximately $141,540. Meanwhile, the total return for the State Street SPDR S&P 500 ETF over the same period was roughly 811% and would have turned a $10,000 investment into $91,400.
Why JPMorgan's succession plan is a big deal for shareholders Dimon's statement that he plans to remain CEO of the company for at least a few more years is good news for shareholders. The executive successfully guided the company through the 2008 financial crisis, issues stemming from the failure of regional banks, and periods of high market volatility. He's generally viewed as a deft leader with a steadying hand and a sober, adeptly analytical view of the banking industry, the stock market, and the global economy at large.
In addition to building an impressive track record at JPMorgan, he issues market commentary that is highly valued by the broader investment community. To a large extent, he's become synonymous with the company -- and that makes finding his successor particularly important. Dimon has delivered strong returns, and investors don't need to worry about his imminent departure, but the eventual leadership transition will be a big moment for the company.
Home Depot má rating Zacks Rank #3 (držet), který naznačuje krátkodobou výkonnost v souladu s vývojem širšího trhu. Konsenzus očekává celoroční EPS ve výši 15,02 USD, což by představovalo meziroční nárůst o 2,3 %.
Home Depot (HD - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Over the past month, shares of this home-improvement retailer have returned -3.3%, compared to the Zacks S&P 500 composite's +1.3% change. During this period, the Zacks Retail - Home Furnishings industry, which Home Depot falls in, has lost 5.7%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
Home Depot is expected to post earnings of $3.86 per share for the current quarter, representing a year-over-year change of +3.2%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.3%.
For the current fiscal year, the consensus earnings estimate of $15.02 points to a change of +2.3% from the prior year. Over the last 30 days, this estimate has changed +0.1%.
For the next fiscal year, the consensus earnings estimate of $16.04 indicates a change of +6.8% from what Home Depot is expected to report a year ago. Over the past month, the estimate has remained unchanged.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Home Depot.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
In the case of Home Depot, the consensus sales estimate of $42.72 billion for the current quarter points to a year-over-year change of +3.3%. The $171.44 billion and $177.52 billion estimates for the current and next fiscal years indicate changes of +4.1% and +3.5%, respectively.
Last Reported Results and Surprise HistoryHome Depot reported revenues of $47.86 billion in the last reported quarter, representing a year-over-year change of +5.7%. EPS of $4.92 for the same period compares with $4.68 a year ago.
Compared to the Zacks Consensus Estimate of $47.23 billion, the reported revenues represent a surprise of +1.33%. The EPS surprise was +4.46%.
Over the last four quarters, Home Depot surpassed consensus EPS estimates three times. The company topped consensus revenue estimates each time over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Home Depot is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Home Depot. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Akciové odměny Goldman Sachs vázané na výkonnost mohou mít pro přibližně 20 vrcholových manažerů hodnotu více než 500 milionů USD; hodnota podílu generálního ředitele Davida Solomona vzrostla z 30 milionů USD na zhruba 100 milionů USD.
Goldman Sachs awarded performance stock to its top executives back in 2021, and three years of share price gains have quietly turned those grants into something much larger than anyone publicly discussed at the time.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
When Goldman Sachs (NYSE:GS | GS Price Prediction) announced its special stock award plan in 2021, chief executive David Solomon’s share was worth about $30 million. At the October 8, 2026 close of $882.59, the same award is valued at about $100 million, a change driven entirely by the share price.
About 20 executives are in line for more than $500 million in total. Performance is measured at the end of October 2026, so the final value can still change.
The stock fell 0.64% on October 8. Pay this large gets scrutiny, but the evidence suggests the plan worked as designed.
Units Granted in 2021 Set the Payout, and the Share Price Did the Rest These are Shareholder Value Creation awards. Goldman granted them to Solomon and president John Waldron in October 2021 and to other management committee members in January 2022.
They are performance share units. Each executive received a fixed number of units, and those units are worth whatever the stock and the performance formula say they are worth when performance is measured. Solomon received 73,264 units, and Waldron received 48,843. Both grants used a reference price of $409.48.
Half the payout depends on Goldman’s total shareholder return, which means price gains plus dividends. The other half compares that return with a peer group of large U.S. banks, capped at 150% of target. Goldman has disclosed the units, the formula, and the cap.
Why the Payout Barely Dents Goldman’s Profits Goldman made $6.63 billion in net income in the second quarter of 2026 alone. Revenue for that quarter was a record $20.34 billion. Compared with those figures, a one-time payout spread across about 20 people is a small cost.
In the same quarter, the firm returned $5.36 billion to common shareholders. The awards are unlikely to limit that capacity going forward.
In 2025, only about 66% of votes approved Goldman’s executive pay, weak support for a large company. Both major proxy advisors opposed the retention awards, which gave Solomon and Waldron $80 million each in January 2025 and vest in 2030.
Solomon’s total pay for 2025 was $47 million. Add the retention award and this payout, and his total exposure rises well above his annual pay. A stock that gained about 180% over three years clears almost any return hurdle. The peer comparison against Goldman’s largest competitors will likely determine how much of the payout above target Solomon actually gets.
What the Pay Plan Means for GS Shareholders Executive pay rose because the stock rose, which is what the plan was built to reward. The cost is small next to Goldman’s earnings, though the weak say-on-pay vote shows investors will push back harder on future awards.
Shares trade about 23.5% below the 52-week high of $1,153.99. TD Cowen just started covering the stock with a Buy rating and a $1,050 price target.
Goldman reports third-quarter results before the market opens on October 13, 2026. Analysts’ average estimates range from about $13.30 to $15.40 per share. The firm has beaten estimates for 6 consecutive quarters.
This view is wrong if third-quarter earnings come in below $13.30 per share. A result that low would suggest the dealmaking surge behind the stock’s run is fading. Goldman’s next proxy statement will show the final payout, and that number will tell you whether the board’s pay discipline matches its profits.
Contact [email protected] for any questions or corrections.
The Goldman Sachs Group, Inc. (NYSE:GS) will release its third-quarter earnings report before the opening bell on Tuesday, Oct. 13.
Analysts expect the company to report quarterly earnings of $13.51 per share, up from $12.25 per share in the year-ago period. The consensus estimate for Goldman’s quarterly revenue is $16.99 billion. It reported $15.18 billion last year, according to Benzinga Pro.
Ahead of quarterly earnings, TD Cowen analyst R. Scott Siefers initiated coverage of Goldman Sachs on Thursday with a Buy rating and a price target of $1,050.
With the recent buzz around Goldman Sachs, some investors may be eyeing potential gains from the company’s dividends too. As of now, Goldman Sachs has an annual dividend yield of 2.27%, which is a quarterly dividend amount of $5.00 per share ($20.00 a year).
So, how can investors generate a regular $500 monthly from its dividend yield?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $264,777 or around 300 shares. For a more modest $100 per month or $1,200 per year, you would need $52,955 or around 60 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($20.00 in this case). So, $6,000 / $20.00 = 300 shares ($500 per month), and $1,200 / $20.00 = 60 shares ($100 per month).
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock’s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
GS Price Action: Shares of Goldman Sachs fell 0.5% to close at $882.59 on Thursday.
PepsiCo snížila výhled růstu EPS pro rok 2026 ze 4–6 % na 1–2 % poté, co provozní zisk divize Frito-Lay North America ve třetím čtvrtletí klesl o 12 %.
PepsiCo has cratered while every major beverage rival rallied, and now Goldman Sachs sees a 40% rebound ahead. But that call rests on three pillars, and one is already showing serious cracks.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
PepsiCo (NASDAQ:PEP | PEP Price Prediction) trades at $128.34, and analysts’ consensus target sits at $148.64. That works out to about 15.8% of implied upside.
PepsiCo owns Lay’s, Doritos, Gatorade, Pepsi and Mountain Dew. Goldman Sachs analyst Bonnie Herzog set a target of $180.00, meaning roughly 40.3% upside from current levels.
Frito-Lay’s Profit Slide and a Guidance Cut Sent Shares 22.9% Below Their 52-Week High The biggest problem is North American snacks. Core operating profit at Frito-Lay North America fell 12% in the third quarter, and segment revenue stayed flat at $6.504B. The stock slipped all year. It was $155.28 around the first-quarter report, $143.30 at the second and $123.74 going into the third. It now sits 22.9% below its 52-week high of $166.41.
Management cut its 2026 outlook for core constant-currency EPS growth to +1% to +2%, down from +4% to +6%, citing rising input costs. Core operating margin contracted 35 bps. Leadership said “the consumer is worse than what we had anticipated and driven mainly by gas prices.”
The quarter itself beat expectations. EPS was $2.34 against a $2.2964 estimate, and revenue was $25.27B. Shares rose 3.73% on the report despite the guidance cut.
Goldman’s $180 Target Rests on Three Pillars, and One Is Cracking Herzog’s first pillar is pricing power at Frito-Lay, assuming PepsiCo can pass through input cost inflation without structural volume decay. The 12% profit drop strains this assumption. Management argues value spending is working: “A category that was negative in volume now is positive in volume.”
The second pillar, international growth, is holding up. Organic growth reached +9% in both EMEA and Asia Pacific, and Latin America Foods revenue rose 14%. Management expects the international business to “cross $40 billion in this year.”
The third pillar is productivity. Per the CEO, “additional structural cost reduction actions are being identified and will be implemented in the coming months.” management expects better Q4 profit performance than Q3, making the next earnings report the first test.
Goldman is an outlier. The Street counts two Strong Buys, three Buys, 18 Holds and one Sell. The 2026 EPS consensus has had 18 downward revisions in 30 days, falling from 8.6388 to 8.5536. The fourth-quarter estimate drew 12 upward revisions in the past week.
Coca-Cola, Monster and Keurig Dr Pepper Rallied While PepsiCo Sank PepsiCo fell on its own. Its beverage peers rallied this year.
Coca-Cola (NYSE:KO) is up 28% year to date at $87.76, with an average target of $94.43 meaning 7.6% upside.
Monster Beverage (NASDAQ:MNST) has gained 13.86% to $43.65, with a target of $50.02 meaning 14.6% upside.
Keurig Dr Pepper (NASDAQ:KDP) is up 15.13% to $31.26, with a target of $36.21 meaning 15.8% upside and no Sell ratings.
On consensus targets, Keurig Dr Pepper and PepsiCo offer similar upside. Goldman’s $180 call is the largest estimate in the group. PepsiCo’s gap exists because its price fell while peers rose.
PepsiCo Trails the S&P 500 by More Than 20 Points This Year PepsiCo is down 7.86% year to date and 7.3% over the past month. The S&P 500 is up 13.5% year to date. Across 24 analysts, the average target of $148.64 meaning 15.8% upside from $128.34.
The valuation is modest at about 15x forward earnings. The dividend yields 4.36% after the company’s 54th consecutive annual increase, which brought the annual payout to $5.92 per share. That 54-year streak puts PepsiCo firmly in Dividend King territory, and we ranked our ten favorites in the club by valuation in a free report here.
A 4% Dividend Yield Meets a $180 Target That Needs a Frito-Lay Turnaround The thesis improves if Frito-Lay’s volume gains turn into profit growth and the new cost cuts bring back margin expansion over the next few quarters. The downside risk grows if input inflation keeps pushing guidance lower and earnings estimates keep falling. In that case, a 15x multiple could just be the new normal.
The setup looks modestly constructive. Getting to Goldman’s $180 requires all three assumptions to hold at once, and the Frito-Lay pillar is clearly weakening. A move toward the $148.64 consensus is more realistic. The yield above 4% provides income while management works to prove the recovery.
Contact [email protected] for any questions or corrections.
Intel má tržní kapitalizaci 562,65 mld. USD, tedy více než společnosti Coca-Cola a PepsiCo dohromady, přesto za posledních 12 měsíců vykázal ztrátu 11,29 mld. USD.
A chipmaker that lost billions last year now commands a valuation that dwarfs two of the world's most profitable consumer giants, and the math holding that together is razor thin.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Intel (NASDAQ:INTC | INTC Price Prediction) lost money over the past year, yet the market values it above Coca-Cola and PepsiCo combined. Intel closed October 8 with a market capitalization of $562.65 billion. Coca-Cola (NYSE:KO) and PepsiCo (NASDAQ:PEP) were worth $552.80 billion together.
Intel’s lead is only about 1.8%. That lead disappears if Intel closes below about $105.21. Intel ended at $107.08, so one down day could erase it.
Beverage Giants Earn the Profits Intel Is Still Chasing Over the trailing twelve months, Coca-Cola and PepsiCo brought in $148.37 billion of revenue and $25.22 billion of profit. Intel had $57.03 billion in revenue and a $11.29 billion loss.
Coca-Cola’s dividend yield is about 2.42%, and PepsiCo’s is about 4.61%. Intel pays no dividend.
Coca-Cola raised guidance after Coca-Cola Zero Sugar grew 16% worldwide. PepsiCo cut its core EPS growth outlook to 2.5% to 3.5% after core operating profit in North American foods fell 12%.
Lens Intel Coca-Cola PepsiCo Growth Engine Data center CPUs Zero Sugar, World Cup marketing International snacks Key Risk Foundry losses Squeezed consumers North American volume Terafab Tests Whether Intel’s Foundry Can Win Outside Volume This spring, Intel joined Elon Musk’s Terafab chipmaking venture. Under the agreement, Tesla (NASDAQ:TSLA) will use Intel’s advanced manufacturing process, and Intel’s chief executive and Musk both reaffirmed that role this week.
A buyer that large confirms Intel’s manufacturing process. Intel Foundry lost $2.1 billion last quarter and brought in only $293 million from outside customers.
A 63x Forward Multiple Assumes Smooth Execution Intel trades at about 63x forward earnings. A forward multiple divides today’s price by the earnings analysts expect over the next year, so it assumes those estimates come true on schedule.
Coca-Cola trades at 25x forward earnings and PepsiCo at 15x, which is typical for steady consumer businesses. Intel’s average analyst target of $118.05 is above the current price.
Intel hit its 52-week low of $32.89 last November and closed 2025 at $36.90. It reached $142.35 on June 30 and is up about 190% this year. On October 8, Intel fell 5.34% while Coca-Cola rose 2.27% and PepsiCo climbed 3.73%.
What Intel Must Prove to Justify Its Lead Intel’s valuation leaves little room for error. Data center revenue rose 59% to $6.26 billion, but the share price assumes Terafab becomes committed foundry volume. Picking out the next huge chip winner early is a pattern we reverse-engineered in a free playbook on the traits past tech runners shared before their big moves.
Coca-Cola’s fundamentals look steadier. Unit case volume grew 5%, and operating margin expanded to 34.9%. Guidance rose, and earnings growth and income came without reliance on an unfinalized contract. The Intel case would improve if outside foundry customers sign public volume agreements.
Contact [email protected] for any questions or corrections.
SummaryAdobe is rated Buy with a 12-month target of $294 and probability-weighted fair value of $274, citing undervalued growth.The current price implies ~3% annual revenue growth, while ADBE has delivered an average of 10.8% over the last four years.Management reiterated a 10.2% ARR growth target and raised full-year guidance, emphasizing a strategic focus on expanding the freemium funnel.Key risks include freemium conversion, contracted demand, and AI compute costs; Q4 ARR and RPO metrics are critical for thesis validation. We Are/DigitalVision via Getty Images
Company Overview Adobe Inc. (ADBE) is a subscription software business catering to creative professionals, enterprises and consumers, with subscriptions making up 96% of FY2025 revenue at $23.8B. It reports two customer groups, Business Professionals & Consumers and Creative & Marketing Professionals, selling through Creative
11 Followers
Analyst’s Disclosure: I/we have a beneficial long position in the shares of ADBE either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Společnost Pfizer získala hodnocení Zacks Rank #2 (Buy), přestože konsenzuální odhad zisku na akcii (EPS) pro aktuální čtvrtletí za posledních 30 dní klesl o 2,4 %.
Pfizer (PFE - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Shares of this drugmaker have returned +0.6% over the past month versus the Zacks S&P 500 composite's +1.3% change. The Zacks Large Cap Pharmaceuticals industry, to which Pfizer belongs, has gained 0.3% over this period. Now the key question is: Where could the stock be headed in the near term?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
Pfizer is expected to post earnings of $0.75 per share for the current quarter, representing a year-over-year change of -13.8%. Over the last 30 days, the Zacks Consensus Estimate has changed -2.4%.
The consensus earnings estimate of $2.98 for the current fiscal year indicates a year-over-year change of -7.5%. This estimate has remained unchanged over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $2.96 indicates a change of -0.6% from what Pfizer is expected to report a year ago. Over the past month, the estimate has changed +0.4%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Pfizer is rated Zacks Rank #2 (Buy).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
For Pfizer, the consensus sales estimate for the current quarter of $16.25 billion indicates a year-over-year change of -2.5%. For the current and next fiscal years, $62.49 billion and $61.05 billion estimates indicate -0.1% and -2.3% changes, respectively.
Last Reported Results and Surprise HistoryPfizer reported revenues of $15.03 billion in the last reported quarter, representing a year-over-year change of +2.6%. EPS of $0.77 for the same period compares with $0.78 a year ago.
Compared to the Zacks Consensus Estimate of $14.45 billion, the reported revenues represent a surprise of +4.04%. The EPS surprise was +13.24%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Pfizer is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Pfizer. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.
Caterpillar zvýšil výhled růstu tržeb pro rok 2026 na střední až vyšší hodnoty v rozmezí nácti procent poté, co růst objemů zvýšil tržby v prvním pololetí o 5,4 miliardy USD.
Key Takeaways Caterpillar added $5.4 billion in first-half 2026 revenues from volume growth.Construction Industries led volume gains with $3.21 billion, followed by Power & Energy at $1.58 billion.CAT raised 2026 sales growth forecast to the mid-to-high teens, driven by strength across all three segments. Caterpillar Inc. (CAT - Free Report) is witnessing strong sales volumes reflecting improving demand across its major businesses. After experiencing prolonged volume weakness, the construction and mining equipment giant has been delivering volume growth since the second quarter of 2025, supported by higher equipment sales to end users and favorable dealer inventory movements. With momentum strengthening across its three primary segments so far this year, the company has raised its full-year revenue outlook.
In the second quarter of 2026, higher sales volumes contributed $3.1 billion, accounting for 19.9% of revenue growth and pushing total sales and revenues to a record $20.5 billion. This followed a 17.3% volume contribution in the first quarter. Overall, volume gains added $5.4 billion to revenues in the first half of 2026.
The improvement marks a significant turnaround from 2025, when Caterpillar reported a modest $237 million increase in sales volume in the second quarter following six consecutive quarters of declines. The recovery was primarily driven by Power & Energy, while Construction Industries and Resource Industries continued to face volume declines. However, momentum broadened in the third quarter of 2025, with all three segments returning to positive volume growth and sustaining the trend since then.
Broad-Based Volume Strength Supports CAT's GrowthConstruction Industries emerged as the largest contributor, generating $3.21 billion in volume growth during the first half of 2026. Higher equipment sales to end users and favorable dealer inventory changes drove the improvement.
Power & Energy added approximately $1.58 billion in volume growth in the first half of 2026, benefiting from strong demand for large reciprocating engines, turbines and related services, particularly for data centers. Increased demand for gas-compression equipment, aftermarket parts and turbines also supported Oil & Gas.
Resource Industries contributed $724 million in volume growth for the period, primarily reflecting higher equipment sales to mining customers.
Encouraged by this momentum, Caterpillar raised its 2026 sales and revenue growth forecast to the mid-to-high teens from its earlier low-double-digit projection.
Looking ahead, Construction Industries should benefit from infrastructure spending, heavy construction activity and investments in data centers. Additional dealer rental fleet loading, including Major Projects activity, should further support volumes.
Resource Industries is positioned to gain from favorable commodity prices, mining fleet replacement demand and strength in Heavy Construction and Quarry and Aggregates.
Meanwhile, Power & Energy should continue benefiting from rising electricity requirements associated with Artificial Intelligence, cloud computing and data centers. Strong demand for prime-power solutions and gas compression, along with a healthy turbine backlog, should sustain growth.
How Are CAT's Peers Performing?Komatsu (KMTUY - Free Report) reported a 4% revenue increase to $6.54 billion in the fiscal fourth quarter of 2026 ended June 30, 2026. Construction, Mining & Utility Equipment sales rose 14.4%, while Industrial Machinery & Others sales increased 21.7%. For fiscal 2027 (ending March 31, 2027), Komatsu expects net sales to grow 4.1%, with gains of 4.3% in Construction, Mining & Utility Equipment and 5.5% in Industrial Machinery & Others.
Terex (TEX - Free Report) reported a 51% year-over-year sales increase to $2.24 billion in the second quarter of 2026. Supported by its backlog and business momentum, Terex expects approximately 7% pro forma sales growth in 2026, with revenues projected between $7.9 billion and $8.2 billion. By segment, Terex expects sales to rise low single digits in Environmental Solutions, low double digits in Materials Processing and Aerials, and high single digits in Specialty Vehicles compared with their respective prior-year baselines.
CAT’s Price Performance, Valuation & EstimatesCAT shares have gained 59.3% so far this year compared with the industry’s 48.9% growth.
Image Source: Zacks Investment Research
Caterpillar is currently trading at a forward 12-month price/earnings (P/E) ratio of 25.10X compared with the industry average of 23.70X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for 2026 points to year-over-year earnings growth of 44.3%, while the 2027 estimate implies growth of 20.7%.
Image Source: Zacks Investment Research
Earnings estimates for Caterpillar for both 2026 and 2027 have moved up over the past 60 days, as shown in the chart below.
Image Source: Zacks Investment Research
Caterpillar stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Fiverr International Ltd. (NYSE: FVRR), the company that is transforming the way the world creates and works together, today announced it will release third quarter financial results for the period ended September 30, 2026, before the market opens on Thursday, October 29, 2026. On that day, management will hold a conference call and webcast at 8:30 a.m. ET to discuss the Company’s business and financial results. Prior to its conference call, Fiverr will issue a press release and post a shareholder letter to its website at https://investors.fiverr.com.
Conference Call and Webcast Details
What: Fiverr’s Third Quarter 2026 Financial Results Conference CallWhen: October 29, 2026, at 8:30 a.m. ETCall Details: To participate in the Conference Call, please dial: Toll-Free: 1-833-630-1956International: 1-412-317-1837 Webcast: A live and archived webcast of the conference call will be accessible from the investor relations section of the Company’s website at https://investors.fiverr.com. About Fiverr
Fiverr’s mission is to transform the way the world creates and works together. We’re shaping the future of work with the world’s leading open platform, seamlessly connecting top talent and cutting-edge technology with businesses around the globe. From expert freelancers in over 750 skilled categories to best-in-class GenAI models and agents, Fiverr provides the most advanced and comprehensive talent and tools for digital services - helping businesses get mission-critical projects done fast and cost-effectively.
From small businesses to Fortune 500 companies, millions trust Fiverr for projects in software and AI development, digital marketing, finance, business consulting, video animation, music, architecture, and more.
Learn how to future-proof your business with exceptional talent and cutting-edge tools at fiverr.com. Follow us on LinkedIn, Instagram, TikTok, and Facebook.
Galvin Gaustad & Stein LLC raised its position in Micron Technology, Inc. (NASDAQ:MU – Free Report) by 834.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,269 shares of the semiconductor manufacturer’s stock after buying an additional 6,491 shares during the quarter. Galvin Gaustad & Stein LLC’s holdings in Micron Technology were worth $7,743,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in MU. Grove Bank & Trust increased its stake in Micron Technology by 3.8% in the third quarter. Grove Bank & Trust now owns 7,932 shares of the semiconductor manufacturer’s stock valued at $8,448,000 after acquiring an additional 289 shares during the last quarter. Financial Enhancement Group LLC bought a new stake in Micron Technology during the third quarter worth $222,000. Conrad Siegel Investment Advisors Inc. boosted its holdings in shares of Micron Technology by 8.4% in the 3rd quarter. Conrad Siegel Investment Advisors Inc. now owns 464 shares of the semiconductor manufacturer’s stock valued at $494,000 after purchasing an additional 36 shares in the last quarter. Hamilton Capital LLC boosted its holdings in shares of Micron Technology by 51.3% in the 3rd quarter. Hamilton Capital LLC now owns 1,389 shares of the semiconductor manufacturer’s stock valued at $1,479,000 after purchasing an additional 471 shares in the last quarter. Finally, Davis Capital Management increased its stake in shares of Micron Technology by 101.6% in the 3rd quarter. Davis Capital Management now owns 123 shares of the semiconductor manufacturer’s stock valued at $131,000 after purchasing an additional 62 shares during the last quarter. 80.84% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity In related news, EVP Sumit Sadana sold 15,000 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $934.29, for a total value of $14,014,350.00. Following the completion of the sale, the executive vice president directly owned 191,021 shares of the company’s stock, valued at $178,469,010.09. The trade was a 7.28% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Scott Allen sold 879 shares of the stock in a transaction that occurred on Thursday, July 23rd. The stock was sold at an average price of $1,000.00, for a total value of $879,000.00. Following the completion of the transaction, the chief accounting officer owned 34,958 shares in the company, valued at approximately $34,958,000. The trade was a 2.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 95,879 shares of company stock worth $90,939,466 in the last three months. Company insiders own 0.24% of the company’s stock.
Micron Technology Price Performance Micron Technology stock opened at $1,035.84 on Friday. The stock has a market capitalization of $1.17 trillion, a price-to-earnings ratio of 13.96, a PEG ratio of 0.19 and a beta of 2.22. Micron Technology, Inc. has a 52-week low of $179.61 and a 52-week high of $1,255.00. The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.94 and a current ratio of 3.31. The stock’s 50 day moving average price is $975.93 and its two-hundred day moving average price is $840.54. Micron Technology (NASDAQ:MU – Get Free Report) last released its earnings results on Wednesday, September 30th. The semiconductor manufacturer reported $33.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $31.77 by $1.65. The company had revenue of $54.23 billion for the quarter, compared to the consensus estimate of $51.33 billion. Micron Technology had a net margin of 63.80% and a return on equity of 92.62%. Micron Technology’s quarterly revenue was up 379.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.03 EPS. Micron Technology has set its Q1 2027 guidance at 37.150-39.150 EPS. On average, equities analysts predict that Micron Technology, Inc. will post 175.82 earnings per share for the current year.
Micron Technology Dividend Announcement The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 29th. Stockholders of record on Wednesday, October 14th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.1%. The ex-dividend date of this dividend is Wednesday, October 14th. Micron Technology’s dividend payout ratio is 0.81%.
Micron Technology News Roundup Here are the key news stories impacting Micron Technology this week:
Positive Sentiment: Strong earnings and forward guidance support the growth outlook. Micron reported fiscal fourth-quarter revenue of $54.23 billion and adjusted earnings of $33.42 per share, both ahead of expectations. Management also projected fiscal first-quarter 2027 adjusted EPS of $37.15-$39.15, implying another sequential increase. Micron’s Latest Earnings Reveal Why the AI Memory Supercycle Could Run for Years Positive Sentiment: AI-related demand remains a major catalyst. More than 75% of Micron’s fiscal 2027 output is reportedly committed, while customers are already discussing 2028 allocations. Record DRAM revenue and surging enterprise SSD demand suggest data-center customers are securing memory supply well in advance. Micron: This Memory Cycle Could End Differently Positive Sentiment: Analyst support remains strong. Zacks upgraded Micron to “Strong Buy,” while D.A. Davidson raised its price target to $3,000 and maintained a Buy rating, citing a potential multiyear shortage driven by AI infrastructure spending. Micron & 2 Profitable Stocks to Buy in October for Big Upside Neutral Sentiment: Valuation and cyclicality remain debated. Bullish analysts view Micron’s roughly six-to-seven-times forward earnings valuation as inexpensive, but skeptics warn that margins may be near a peak and that memory prices could eventually normalize. A $600 million settlement with Netlist also removes a legal overhang but adds a material cost. Micron Technology, Netlist Settle Patent Dispute for $600 Million Negative Sentiment: Investors reacted negatively to weaker-than-expected AI revenue concerns. A report that OpenAI’s annualized revenue was below expectations triggered a broader selloff in AI and semiconductor stocks. Analysts said the figure may reflect reporting differences rather than a deterioration in AI demand, but the news heightened concern about crowded AI valuations. Micron, Nvidia and AI chip stocks fall as report on OpenAI’s revenue causes undue concern Negative Sentiment: A Taiwan labor dispute adds operational risk. Workers at Micron’s major Taiwan manufacturing sites authorized a strike over bonus changes. No walkout has been announced, but a disruption could threaten production and increase costs. Micron’s Taoyuan union in Taiwan secures authorisation to strike Negative Sentiment: Samsung’s record profit did not reassure memory investors. Although Samsung reported sharply higher operating profit, the slower pace of growth and concerns that the memory cycle is nearing a peak reinforced fears that Micron’s exceptional earnings growth may decelerate. The Memory Trade Cools After Samsung’s Preliminary Results Disappoint Analyst Upgrades and Downgrades MU has been the subject of a number of research analyst reports. Bank of America boosted their price target on Micron Technology from $950.00 to $1,500.00 and gave the stock a “buy” rating in a report on Tuesday, June 23rd. Raymond James Financial reiterated an “outperform” rating on shares of Micron Technology in a research report on Thursday, October 1st. Stifel Nicolaus boosted their target price on Micron Technology from $550.00 to $1,500.00 and gave the stock a “buy” rating in a research note on Thursday, June 18th. Barclays increased their target price on shares of Micron Technology from $1,175.00 to $2,000.00 and gave the stock an “overweight” rating in a report on Thursday, June 25th. Finally, BNP Paribas Exane raised their price target on shares of Micron Technology from $615.00 to $1,700.00 and gave the company an “outperform” rating in a research note on Thursday, June 25th. One investment analyst has rated the stock with a Strong Buy rating, forty-one have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $1,407.88.
Check Out Our Latest Report on MU
Micron Technology Profile (Free Report)
Micron Technology, Inc is a semiconductor company that develops and manufactures memory and storage solutions. Its product portfolio includes dynamic random-access memory (DRAM), NAND flash memory, three-dimensional XPoint-related technologies, solid-state drives, and high-bandwidth memory products designed for demanding computing applications.
The company serves customers across the data center, artificial intelligence, networking, automotive, industrial, mobile, consumer electronics, and embedded markets.
Featured Articles Five stocks we like better than Micron Technology Want Private-Market Access to Kalshi and Polymarket? Try This ETF Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push Want to see what other hedge funds are holding MU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Micron Technology, Inc. (NASDAQ:MU – Free Report).
Receive News & Ratings for Micron Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Micron Technology and related companies with MarketBeat.com's FREE daily email newsletter.
Micron ve 4. fiskálním čtvrtletí zvýšil tržby meziročně o 379 % na rekordních 54,2 mld. USD a v 1. čtvrtletí fiskálního roku 2027 očekává tržby ve výši 61,5 mld. USD.
Michael Burry and Jim Cramer aren't the first two investors you'd expect to agree on a stock, but their disagreement over Micron Technology (MU +0.61%) is particularly interesting.
Burry, the investor made famous by The Big Short, recently closed his outright short position in Micron and replaced it with put options. Cramer, meanwhile, warns that investors betting against the memory chip maker are "digging their own grave."
After Micron's latest earnings report, I think Burry's bet faces a particularly difficult obstacle: the company he's betting against doesn't look much like the highly cyclical memory business investors became exhausted by over the last several decades.
Image source: Getty Images.
Michael Burry is betting Micron stock gets cut in half Burry isn't simply bearish on Micron stock. His trade actually has a deadline before it potentially pays off. On Sept. 28, Burry notified subscribers to his investment newsletter that he had replaced his Micron short position with put options expiring in June 2027 with strike prices around $500. At the time, Micron was trading above $1,000. Put options give an investor the right to sell their shares at a predetermined price. Burry's position will become increasingly valuable if Micron stock plunges toward or below $500.
Burry says artificial intelligence (AI) is a bubble and it could burst sooner than most investors expect. He is so confident in this idea that he moved his timeline for an AI-driven crash forward and wanted additional leverage for such a trade.
This isn't a vague prediction that Micron will someday experience a downturn. Burry is effectively betting that something goes seriously wrong with the AI market before next summer. That's a really bold call considering what Micron just reported.
Premium Feature
Moneyball Superscore
91/100
Today's Change
(
0.61
%) $
6.32
Current Price
$
1,042.16
Cramer warns that short sellers are missing an AI-driven transformation Two days after Burry disclosed his new Micron position, the company delivered a monster fiscal fourth quarter. Revenue for the quarter reached a record $54.2 billion, up 379% year over year. Adjusted earnings per share (EPS) surged to $33.42 per share, while adjusted gross margin reached an astonishing 87%.
Management expects things to get even better. For the first quarter of fiscal 2027, Micron guided for $61.5 billion in revenue and adjusted earnings of $38.15 per share. Management made it clear that they expect memory supply demand conditions to become even tighter during 2027 and 2028.
This growth is the backdrop behind Cramer's argument. Following Micron's earnings, Cramer argued that investors still treating Micron like a commoditized, cyclical memory manufacturer are missing the company's secular AI-driven transformation.
I would not bet against Micron Micron's bull case extends well beyond AI data centers. High-bandwidth memory (HBM) and advanced DRAM is increasingly needed across different pockets of AI infrastructure -- from autonomous vehicles, aerospace and defense, medical technology, industrial applications, and even humanoid robotics.
Moreover, the company has signed 26 strategic customer agreements and more than 75% of its expected 2027 output is already committed. Remaining performance obligations (RPO) have climbed to roughly $150 billion.
Lastly, Micron finished fiscal 2026 with $68.3 billion in net cash and generated $62.3 billion of adjusted free cash flow for the year. However, the company only repurchased $650 million of stock. Management is planning to return 100% of excess cash to shareholders over time, primarily through share repurchases. That authorization could create a powerful new source of demand for Micron shares.
Of course, today's premium prices for memory and 80%-plus profit margins won't last forever. AI infrastructure spending could slow, while new manufacturing capacity should eventually balance supply and demand. After Micron's spectacular rally, expectations are undeniably high. Although Burry could ultimately be right that another memory cycle is coming, I see a problem with his clock.
His June 2027 puts do not give the bear thesis several years to materialize. Meanwhile, Micron is telling investors that supply is going to remain tight through fiscal 2027 and 2028 while simultaneously forecasting higher revenue, signing multi-year supply agreements, expanding into new AI markets, and preparing to deploy enormous cash toward buybacks. That's a lot to bet against over the next eight months. I think Micron's record revenue, enormous contracted demand, new AI use cases, and upcoming share repurchases suggest the stock is a screaming buy right now.
Tržní kapitalizace společnosti Micron dosáhla 1,17 bilionu USD, čímž překonala společnou hodnotu společností Coca-Cola, PepsiCo, McDonald’s, Disney, Starbucks, Nike a Chipotle.
Most Americans can name a Coca-Cola before they can name a single Micron product, yet Wall Street just handed the obscure memory chip maker a valuation that leaves seven of the world's most recognized consumer brands in the dust.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
In a typical week, most Americans buy a Coke, a Big Mac or a latte. Few of them could name a single product made by Micron Technology (NASDAQ:MU | MU Price Prediction), yet the memory maker closed Oct. 8 with a market cap of about $1.17 trillion.
That is more than the combined $1.104 trillion of Coca-Cola (NYSE:KO), PepsiCo (NASDAQ:PEP), McDonald’s (NYSE:MCD), Disney (NYSE:DIS), Starbucks (NASDAQ:SBUX), Nike (NYSE:NKE) and Chipotle Mexican Grill (NYSE:CMG). Investors now pay for exposure to the AI buildout.
The lead is thin. A drop of about 5.5% would erase it if the consumer names stayed flat. One bad trading day could do that.
Micron Earns More Than All Seven Brands Combined Micron earned $84.97 billion in fiscal 2026, about 1.7 times the estimated $49.1 billion the seven consumer companies earned together over the trailing year.
Micron’s latest quarter alone produced $37.70 billion in profit, equal to about 77% of the group’s annual total.
Metric Micron Seven Consumer Companies Market Cap $1.17 trillion $1.104 trillion Revenue $133.2 billion $371.6 billion Annual Profit $84.97 billion about $49.1 billion Margins Explain Why Smaller Sales Earn More The seven brands sell far more than Micron but keep far less of each sale. Micron’s non-GAAP gross margin reached 87.0% in fiscal Q4, up from 45.7% a year earlier, because demand for AI memory such as HBM and DDR5 is growing faster than supply.
Nike trades near a 13-year low, while PepsiCo hit its lowest level since 2020 before bouncing on results that cut its outlook for core EPS growth to 2.5-3.5%.
A Single-Digit Multiple Shows Doubts About How Long This Lasts Micron’s valuation sits at about 6x forward earnings, pricing today’s profits like the peak of a cycle. Customers have signed 26 strategic agreements carrying about $150 billion in remaining performance obligations.
CFO Mark Murphy said, “Even at floor prices, we expect margins meaningfully above any prior cycle peak margins.”
Revenue guidance of $61.5 billion, plus or minus $1.5 billion, for next quarter shows demand is still climbing. Memory is the most cyclical part of the chip industry; high prices bring new supply, and a small number of AI customers account for much of the demand. The same expansion is lifting the power, cooling, and networking vendors we profiled in a free report on seven AI infrastructure stocks that aren’t chipmakers.
The stock fell 4.79% on Oct. 8 in a broad selloff of AI chip stocks and sits about 17.5% below its record intraday high from June 25, 2026.
Should You Buy or Sell MU Stock At about 6 times forward earnings, the price assumes a steep downturn. More than 75% of the company’s calendar 2027 output is already committed to customers, making a downturn before 2028 less likely.
A beta of 2.226 means the stock tends to swing about twice as much as the market. Coca-Cola raised its guidance and grew Zero Sugar volume 16%, though its earnings will grow far more slowly.
I would reconsider if pricing for HBM, the high-bandwidth memory used in AI chips, weakens in 2028 or if customers stop paying cash down payments to lock in supply.
Contact [email protected] for any questions or corrections.
Analytik Gil Luria ze společnosti DA Davidson stanovil pro Micron 12měsíční cílovou cenu 3 000 USD, což je téměř o 200 % více než úterní závěrečná cena.
DA Davidson analyst Gil Luria shocked the market on Wednesday by setting a $3,000 12-month price target for memory maker Micron (MU +0.61%), representing nearly 200% upside from the stock's Tuesday close. The stock has already risen about 1,500% since last April and was up 266% year to date.
Micron is one of the big three memory makers, along with its South Korean counterparts Samsung (SSNLF +0.00%) and SK Hynix (SKHY +1.19%). The company derives about three-quarters of its revenue from DRAM (dynamic random access memory) and a quarter from NAND flash memory. The company has been riding the memory supercycle, seeing a huge surge in revenue and gross margins as a serious shortage has pushed memory prices sharply higher.
Let's look at the cases for and against this AI stock delivering such a huge upside from here.
Premium Feature
Moneyball Superscore
91/100
Today's Change
(
0.61
%) $
6.32
Current Price
$
1,042.16
The bull case Luria is now the biggest Micron bull on Wall Street, and his investment thesis is quite simple. He thinks this memory cycle is much different than prior cycles, and the current supply-and-demand imbalance will last significantly longer than expected. This, in turn, will lead the market to rerate the stock to a higher multiple.
The analyst called memory "a lever for better AI performance" and believes there has been a big structural shift in the market. He pointed to Micron's long-term supply contract agreements and the strength of the companies making these deals. Meanwhile, he thinks the trend of memory de-specing -- the use of less memory per AI processor -- could actually lead to more AI processor sales and boost overall memory sales.
I think Luria is correct when he says this memory cycle is different from past ones, as the AI infrastructure build-out has created what clearly looks like a structural tailwind. High-bandwidth memory (HBM) has become an essential part of the AI infrastructure story, as graphics processing units (GPUs) and other AI chips need to be packaged with copious amounts of HBM to rapidly feed them data to process -- or else they will spend too much of their time idle. Meanwhile, memory makers' ability to increase their production capacity is constrained by a host of factors, from a limited ability to secure new EUV (extreme ultraviolet) lithography machines to the time it takes to build new clean rooms. In addition, HBM requires roughly three times the wafer capacity of conventional DRAM, which is straining silicon wafer supply for all types of memory.
Image source: The Motley Fool
The bear case That said, I think there are some flaws in Luria's argument. First, HBM is not the main direct driver of Micron's huge revenue growth and suddenly robust margins. In fact, the company derives the least amount of its revenue from HBM of any of the big three memory makers. While in Q2, the company had a 24% share of the global DRAM market, it held only an 18% share of the HBM market, compared to 33% for Samsung and 50% for SK Hynix. (Those numbers add to 101% due to rounding.)
As a result, Micron is enjoying more of the piggyback action from the current state of the memory market. With the big three memory makers focusing most of their resources on HBM to keep up with demand, prices for conventional DRAM and NAND have risen at a much quicker pace than HBM prices. This has benefited Micron more than its rivals.
This can be seen in the results of Micron compared to those of HBM leader SK Hynix, which has close ties to Nvidia. Last quarter, Micron's revenue increased nearly fivefold to $55.2 billion, and its gross margin went from 44.7% a year ago to 86.8%. This was largely due to price increases, as its shipments for DRAM rose by just a mid-single-digit percentage sequentially, and NAND shipments grew by 10%. By comparison, SK Hynix saw its revenue climb 257% year over year on sequential shipment growth (high-single-digits for DRAM and mid-teens for NAND), while its gross margin rose from 53% a year ago to 83%.
Why the HBM story is a good one The simple fact is that if you back into the numbers, less than 10% of Micron's revenue is coming from HBM (roughly 20% market share of what is projected to be a $55 billion HBM market this year). It is much more reliant on conventional DRAM and NAND prices remaining high than on HBM demand, and that's why I wouldn't buy the stock now.
Akcie AMC letos vzrostly o 86 %, protože domácí tržby z kin jsou nejvyšší od roku 2019; společnost AMC má překonat tehdejší tržby ve výši 5,5 miliardy USD.
There is green being made on the silver screen this year. AMC Entertainment (AMC -0.17%) -- yes, that multiplex operator that had its meme stock glow up and blow up in 2021 -- is one of this year's more surprising winners. The shares are up 86% in 2026, naturally trouncing the market and likely your own AMC-less portfolio.
As she ascended the stairs of an empty AMC movie theater in the fall of 2021, Nicole Kidman predicted this day would happen. "We come to this place for magic," Kidman says.
After a long way down -- AMC shares are still down 99% over the past five years -- it seems as if the free-falling exhibitor is finally ready to turn around. Finally! It's the magic show that Kidman once promised.
Image source: Getty Images.
The others AMC peers have been shining in the spotlight for years. Smaller rivals Cinemark (CNK +0.27%) and Marcus (MCS +0.22%) -- up 74% and 45%, respectively, over the last five years, which have pained the industry leader -- are now profitable and have even resumed paying quarterly dividends.
AMC isn't expected to turn an annual profit until 2028. Resuming the dividend that was suspended in 2019 might take longer. Those aren't the ticket stubs being torn here. We're finally at the point where even all of the distractions and dilution that have plagued AMC and its investors in the last several years can't stop the industry's overall momentum.
Premium Feature
Moneyball Superscore
46/100
Today's Change
(
-0.17
%) $
-0.01
Current Price
$
2.88
Practical magic, too AMC stock is rallying for a good reason this year. Domestic box office receipts for multiplex operators are at their highest level since 2019. AMC should top the $5.5 billion in revenue it generated that year, largely because folks are spending more on snacks, beverages, and collectibles once they get there.
I knew I was going to face some head-shaking when I became an AMC shareholder last month. AMC CEO Adam Aron did unsophisticated investors dirty by taking advantage of the meme-stock craze to float dilutive preferred shares and dismiss his own company's operating inefficiencies as smaller rivals returned to profitability.
Despite the company's financial shortcomings, it has quietly built up an empire that is thriving under the new normal. Folks are coming back to the movies, particularly younger filmgoers who many figured would never return to the cinema experience of their parents.
Its AMC Stubs loyalty program is keeping fans close. And its AMC Stubs A-List monthly subscription plans are keeping hardcore film buffs even closer.
The studios are doing their part, putting out compelling movies that folks increasingly feel they have to experience on the largest screen available. AMC has turned to prerecorded and live concerts to bring audiences back. If it can match the nimble cost-effective operations and prudent balance sheet management of Cinemark and Marcus, this stock can double again from here by the time it finally turns an annual profit.
You don't have to like the past -- especially for those who suffered it from the inside as shareholders -- to appreciate the future. The projector's rolling again.
MercadoLibre zvýšila v první polovině roku 2026 tržby o 50 % na 19 mld. USD, čistý zisk však klesl o 13 % na 883 mil. USD kvůli nižším maržím a vyšším opravným položkám.
Picking a stock to buy and hold for 20 years is a risky proposition, no matter how conservative the stock. A lot can happen in that time, and what may look like an impenetrable competitive advantage in one decade could disappear by the next.
That said, MercadoLibre (MELI +0.72%) may just be a stock worth putting in your long-haul buy-and-hold portfolio. Its diverse digital businesses, which thrive on synergies, should make the consumer discretionary stock a winner for at least 20 years.
Image source: Getty Images.
The strengths of MercadoLibre MercadoLibre has combined businesses such as e-commerce, fintech, and logistics into a single operation. These enterprises work both separately and together to capitalize on opportunities.
One common reason why some hesitate to invest in MercadoLibre is that it operates in Latin America, a region often subjected to political and economic turmoil. Still, MercadoLibre is also adept at turning the region's challenges into opportunities.
Because so many people in its core markets lacked access to digital payment options, it chose to form its own fintech business, Mercado Pago. This has given millions of previously unbanked customers a way to participate in the financial system. Additionally, the lack of fulfillment and shipping options in Latin America led the company to create Mercado Envios, a business that brought next-day delivery and other services to the region.
This integrated approach is working. MercadoLibre booked revenue of $19 billion in the first half of 2026, a 50% year-over-year increase. Despite that massive improvement, its net income fell by 13% to $883 million over the same period. This was in part because the company's e-commerce margins shrank as competition increased. It also had to increase its allowance for non-performing loans as its loan book grew dramatically.
However, long-term investors should appreciate that it is foregoing some profits now to grow its business for the long term. Its lower e-commerce margins today will likely lead to less competition later, which should allow it to increase its market share. Also, as it becomes better at evaluating borrowers, its growing loan book will probably benefit the company's bottom line.
Furthermore, MercadoLibre compares well with other e-commerce stocks such as Amazon. MercadoLibre's market cap is about $94 billion, a tiny fraction of Amazon's $2.8 trillion market cap. While there are no guarantees, Amazon's history may hint at MercadoLibre's future as it captures more of its addressable market.
Premium Feature
Moneyball Superscore
84/100
Today's Change
(
0.72
%) $
13.40
Current Price
$
1,870.06
Finally, MercadoLibre now trades at a P/E ratio of 50. During Amazon's growth years, it routinely supported higher valuations than that, suggesting MercadoLibre stock is relatively inexpensive right now. As the company translates its rapid revenue growth into larger net profits, the stock could head significantly higher over the next 20 years.
Největší akcionář společnosti Eli Lilly, Lilly Endowment, podal oznámení o plánovaném prodeji 300 000 akcií v hodnotě 347,247 milionu USD, aby splnil povinné výplaty nadace.
Lilly's largest shareholder just filed to unload nearly $350 million in stock while analysts keep raising their price targets, and those two facts point in opposite directions for investors trying to read the room.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Eli Lilly (NYSE:LLY | LLY Price Prediction) closed at $1,169.60, and the average Wall Street price target is $1,329.21. That puts the stock about 13.6% below where analysts think it should trade.
This week’s attention came from Lilly Endowment, the Indianapolis charitable foundation and Lilly’s largest shareholder. It filed a Form 144 to sell 300,000 shares worth $347,247,000 through J.P. Morgan Securities.
The filing arrived with the stock about 9.5% below its record intraday high of $1,292.65. Lilly leads the GLP-1 drug market. It has a market value of about $1.04 trillion, so a large sale by its biggest holder can look like a warning.
That gap more likely reflects a mispriced stock than a target that has fallen behind the market.
A Charity’s Payout Calendar Explains This Sale Private foundations must pay out roughly 5% of their assets annually. An Endowment spokeswoman explained that the foundation must raise additional cash to cover its required distribution.
J.K. Lilly Sr. and his sons founded the Endowment in 1937, and the shares were a gift from the J.K. Lilly Sr. Trust in 1948. The foundation funds community development, education, and religion, mostly in Indiana.
As of June 30, it held 90,376,978 shares, or 9.6% of the company. That is more than BlackRock’s (NYSE:BLK) holding, which totals 67.5 million shares.
The proposed sale represents about 0.33% of that position. A legally required payout runs on a set schedule, so it tells you nothing about Mounjaro demand or pipeline risk.
Thursday’s Swing Left Lilly’s Franchise Intact Thursday’s session was volatile. Shares fell as low as $1,131.21, nearly 5% below the prior close, before closing down 1.61%.
The business has improved since the August peak. Second-quarter revenue was $22.97 billion, up 47.7%. Mounjaro brought in $9.94 billion and Zepbound $4.93 billion.
About 6 out of 10 U.S. obesity prescriptions are for Lilly drugs. Lilly’s share of the international incretin market has reached roughly 55%. Management also raised 2026 revenue guidance to $85 billion to $87 billion.
The weak spot is pricing. U.S. price fell 9% excluding rebate adjustments. Management expects wider access to keep driving net prices down while higher volume makes up the difference.
Analysts Are Raising Targets as the Stock Falls Morgan Stanley (NYSE:MS) raised its target to $1,430, and Cantor Fitzgerald moved to $1,440 from $1,410. Overall coverage includes six Strong Buy, plus 19 Buy, three Hold, one Sell and one Strong Sell ratings.
These target increases during a drop follow the earnings report. Lilly reported non-GAAP EPS of $8.38 against expectations of $6.58, even after $3.03 per share of acquired IPR&D charges.
At about 24x forward earnings, the stock is priced below what its growth rate would support. Targets are estimates; I would be wrong if price erosion exceeds prescription growth.
Endowment Selling Adds Little Supply In January, the Endowment sold 293,446 shares for about $322 million. It sold another 302,403 for about $385.7 million on August 19, the day Lilly hit its record.
The foundation sold near the top in August and is selling again at a lower price, as a schedule is at work and the payout must be met regardless of stock performance.
The 300,000 shares equal about 14% of a typical recent day’s volume of roughly 2.13 million shares. Spread over several sessions, that is tiny against a float of 888.95 million shares.
Should You Buy or Sell LLY Stock Lilly is up 9.36% this year, behind the S&P 500’s 13.49%. Over the past 12 months, however, it has gained 39.17%.
Third-quarter results arrive on October 29, before the open. The report needs to show growth from the Medicare Bridge program and Foundayo sales above the second quarter’s $67 million in U.S. revenue.
Guidance also has to hold at or above $35.50 to $36.50 in non-GAAP EPS, even with lower U.S. prices. If management cuts that range, the target gap is more likely a warning than an opportunity.
Lilly looks undervalued at this price relative to analyst targets. The downside scenario depends on net prices falling faster than prescriptions grow. The Endowment’s sale says nothing about that, while the price drop has already priced in a slowdown that has not shown up in the results.
Contact [email protected] for any questions or corrections.
Apple just got hit with a report that it slashed iPhone 18 Pro component orders, and the fallout is splitting the chip sector in a way that raises questions about whether premium smartphone demand is cracking at exactly the wrong…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Apple (NASDAQ:AAPL | AAPL Price Prediction) stock is at $331.22, down 3%, after a report that the company has cut component orders for its iPhone 18 Pro lineup. The pressure is landing on Apple and its iPhone suppliers, while the wider chip sector is climbing.
Meanwhile, Skyworks Solutions (NASDAQ:SWKS) stock is at $78.95, down 2%, a slightly smaller decline than the drop in Apple stock. Qualcomm (NASDAQ:QCOM) stock is at $176.64, up 0.4%, inching higher as Apple stock slips.
Semiconductor stocks broadly are moving the other way, with the iShares Semiconductor ETF (NASDAQ:SOXX) up 2%. Large-cap tech is stronger too, with the Invesco QQQ Trust (NASDAQ:QQQ) up 0.7% even though Apple ranks among the fund’s largest holdings. That split marks the reaction as specific to Apple and its handset supply chain.
Report of iPhone 18 Pro Order Cuts Sparks Selloff A report stated that Apple has instructed some suppliers to scale back production of parts for its latest Pro and Pro Max models, with October component orders reduced by 15% to 20% compared with initial projections. The report cited weaker-than-expected demand, along with rising prices for memory chips and other components that have pushed Apple’s manufacturing costs higher.
Memory costs were already a known pressure point for Apple. Tim Cook addressed this on Apple’s July earnings call. He stated, “we see the market pricing for memory continuing to increase, which could drive an increasing impact on our business, and we’re continuing to evaluate this.” Apple’s management also projected that supply constraints would rise significantly in fiscal Q4 2026 across iPhone, Mac and iPad.
Skyworks Sits Closest to iPhone Volumes Skyworks supplies radio-frequency front-end components for Apple’s iPhones, so its revenue tracks handset unit volumes and the dollar content per device, and during a July earnings call, Skyworks management guided for a seasonal mobile ramp tied to new product launches at the company’s largest customer. Even after the decline, Skyworks stock is up 27% year to date.
Skyworks management has also argued that rising radio-frequency complexity could lift dollar content per phone over time. On that call, a company executive stated, “What’s in the rear view mirror is content shrinking over time. What’s in the headlights and in the windshield now is RF content growing.” That view supports the longer-term case for Skyworks, even as its near-term revenue still depends on how many iPhones get built.
Qualcomm sells modems and processors across a wider customer base, which spreads the company’s exposure to any single handset program, and in July, the company’s management noted materially lower share in new iPhone launches, while automotive, Internet of Things and data center sales give Qualcomm growth outside handsets. Year to date, Qualcomm stock is up 5%, well behind Apple shares and Skyworks shares.
Order Cuts Revive the Premium Demand Debate The bear case holds that order cuts this early in a cycle point to premium iPhone demand falling short at higher price points. That concern carries extra weight with Apple stock up 22% year to date, since a strong run leaves less buffer for disappointment. Higher memory prices add a profitability angle, because Apple’s management said in July that those costs primarily drove its sequential gross margin change.
However, the bull case notes that the reported cut applies to October orders, leaving Apple’s total production and sales forecast outside its scope. Apple also launched its premium models first this cycle, with the standard model and an upgraded Air following early next year, which can shift component volume into a later period.
What to Watch Now The question now is whether other Apple suppliers confirm the scale of the October reductions in their own updates. A wider gap between the iShares Semiconductor ETF and Apple stock would reinforce the case that the pressure is confined to the handset chain. In the meantime, it’s not a bad idea to keep any AAPL share position sizes small.
Contact [email protected] for any questions or corrections.
If there were any doubt that AI data center owners/operators are serious about using nuclear power to shore up their energy supply, Alphabet and Amazon just erased it.
Last week, the e-commerce powerhouse made a 20-year commitment to purchase electricity from Constellation Energy's (CEG -4.85%) Calvert Cliffs Clean Energy Center in Maryland. Then, early this week, Google's parent company Alphabet made a separate-but-similar 20-year deal with Constellation to purchase nuclear-generated power from 11 different facilities in Illinois, Pennsylvania, and New Jersey.
Read between the lines: The tech industry knows that nuclear energy will feature prominently in its future mix of power sources, largely because it's proven, scalable, and ready to go right now.
Image source: Getty Images.
Constellation is obviously well-positioned to benefit from this tailwind, in that it already generates about 80% of the nation's nuclear power output. That doesn't necessarily make its stock the top bet for interested investors.
CEG shares have more than tripled in value over the past three years in anticipation of this swell of demand. The result is an unusually expensive utility stock with little dividend yield.
The best way of plugging into this trend, rather, is arguably Cameco (CCJ +0.79%), which supplies the low-enriched uranium-235 required by most modern nuclear power facilities. Although the sales and consumption cycle of uranium-235 is relatively slow, the World Nuclear Association believes the nuclear energy industry's total power output could triple between now and 2050, with the ramp-up unlikely to materialize in earnest until 2030 as several dozen new nuclear power plants currently under construction come online. Others will begin construction in the meantime.
Today's Change
(
0.79
%) $
0.69
Current Price
$
87.81
The kicker: Cameco owns 49% of Westinghouse, which supplies half of the world's nuclear energy industry with equipment and technology, including reactors.
Cameco shares jumped in response to the news of Alphabet's power purchase agreement with Constellation, by the way. Even so, the stock's still about 35% below analysts' consensus target price of $125.75. That's not a bad way to start a new trade.
James Brumley has positions in Alphabet. The Motley Fool has positions in and recommends Alphabet, Amazon, Cameco, and Constellation Energy. The Motley Fool has a disclosure policy.
JetBlue získala konečné schválení FAA k převzetí 22 slotů na letišti LaGuardia po zkrachovalé společnosti Spirit Aviation, což posiluje její cenovou sílu na kapacitně omezených trasách.
Airlines face a complex operating environment characterized by rising fuel costs and shifting consumer travel patterns. In this environment, the right airport assets can quickly change a company’s financial outlook.
JetBlue Airways Today
$3.86 -0.06 (-1.40%)
As of 09:43 AM Eastern
This is a fair market value price provided by Massive. Learn more.
$3.79▼
$6.62$5.02
JetBlue Airways NASDAQ: JBLU recently secured final Federal Aviation Administration approval to absorb 22 takeoff and landing slots at LaGuardia Airport, previously held by the now-bankrupt Spirit Aviation OTC: FLYYQ.
Get JetBlue Airways alerts:
Slot-constrained airports offer high barriers to entry and distinct pricing power. Acquiring these slots at a steep discount gives JetBlue an immediate edge on pricing. This regulatory green light prompted Citigroup NYSE: C to upgrade JetBlue to a Neutral rating, noting that valuation risks are largely priced in at current levels.
By focusing more on premium travelers, JetBlue is insulating its operations from industry headwinds and setting up an asymmetric risk/reward profile for contrarian investors. The acquisition of these slots represents just the first phase of a broader strategic pivot.
Ground Control: How 22 New Slots Establish a Valuation FloorCommercial aviation relies heavily on hub efficiency, and LaGuardia operates under strict federal slot constraints. An airline cannot decide to fly more planes into the facility on a whim. The carrier must own the right to land at a specific time. Because these slots rarely change hands outside of bankruptcies or mergers, securing them provides immediate pricing power on select routes.
Citigroup analysts recognized this structural advantage and issued an upgrade, suggesting JetBlue's stock has a price floor near $4. JetBlue shares have fallen about 75% over five years, pushing its market capitalization to around $1.5 billion. At this depressed valuation, the market has already priced in the worst-case scenarios for JetBlue’s balance-sheet distress and leadership changes.
The departure of activist investor Carl Icahn and his group from the JetBlue board in late August removed a layer of corporate friction. Activist exits frequently signal near-term capitulation, clearing the way for management to execute turnarounds without constant proxy pressure. Adding high-yield real estate at LaGuardia gives current leadership a tangible asset to leverage as they rebuild the route network.
Top-Line Tailwinds: JetBlue Gains Altitude in Q2Turnarounds in capital-intensive industries rarely happen overnight, but early indicators usually surface in top-line revenue before trickling down to net income. JetBlue posted a 3-cent earnings-per-share beat in its second-quarter report, reporting a loss of 66 cents per share versus a projected 69-cent loss. The airline delivered a 14.5% year-over-year revenue increase.
This top-line expansion indicates that the company's operational adjustments are gaining traction. The balance sheet remains highly leveraged, carrying a debt-to-equity ratio of about 5.04 and a current ratio of about 0.70. Net margins are compressed at negative 9.32%, and trailing net income is a loss of about $602 million.
These metrics highlight the severity of the past few years, but they also frame the opportunity. When an enterprise with about $1.5 billion in market capitalization expands revenue by 14.5% in a single quarter, its underlying cash flow dynamics begin to shift.
In capital-heavy sectors, debt is a tool, not just a liability. The key is ensuring operating cash flow outpaces the cost of servicing that debt. The recent revenue jump provides a catalyst needed to reassure credit markets. As long as top-line momentum continues, refinancing existing obligations is a manageable administrative task rather than an existential threat.
Cruising Altitude: Why RASM Is JetBlue's New North StarThe broader passenger airline sector faces margin compression driven by rising jet fuel costs. In September, JetBlue cut its capacity-growth outlook and raised its third-quarter fuel price forecasts, directly linking the scale-back to weather and fuel constraints.
Cutting capacity is a defensive move, but JetBlue management is counterbalancing this by aggressively rolling out high-margin products. The company recently introduced BlueFirst domestic first-class seating and expanded its premium Mint lounge network. This transition targets a critical airline efficiency metric.
Basic economy seats offer thin margins and are highly sensitive to fuel price fluctuations. Premium seating commands higher fares that more easily absorb elevated fuel costs. By shifting the product mix toward business and premium leisure travelers, JetBlue actively drives revenue per available seat mile (RASM) higher, even as overall flight capacity shrinks.
Airlines use pricing systems to sell the right seat to the right customer at the right time. When an airline holds slots at a heavily restricted airport, it can set higher fares, knowing competitors cannot add flights to undercut them.
That built-in protection provides steady revenue that helps offset turbulence in less protected regional routes. The LaGuardia slots pair perfectly with this strategy, as routes originating from major business hubs naturally support higher concentrations of premium bookings.
Institutional Investors Book Their Tickets for the ReboundDerivatives market positioning suggests institutional investors are anticipating a stabilization in share price. A significant volume of call options traded in mid-September, signaling that smart money expects the support level to hold.
Wall Street remains cautious, with a consensus rating leaning toward Reduce based on five Sell ratings and eight Hold ratings. Despite the bearish sentiment, the average 12-month price target of $5.02 implies about 29% upside from current levels. This divergence between ratings and price targets often occurs at cycle bottoms, where analysts hesitate to issue Buy ratings but acknowledge the math points to higher future valuations.
Fasten Your Seatbelts for a Strategic TurnaroundAirlines require close monitoring because they're highly sensitive to crude oil markets and consumer spending habits. JetBlue faces real debt challenges and economic headwinds. But its new airport slots, added premium seating, and double-digit revenue growth provide a viable path to recovery.
Investors looking for contrarian value in the industrial sector might watch JetBlue's upcoming earnings reports to see whether the premium product strategy continues to lift RASM.
Should You Invest $1,000 in JetBlue Airways Right Now?Before you consider JetBlue Airways, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and JetBlue Airways wasn't on the list.
While JetBlue Airways currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Lam Research za 10 let zvýšila hodnotu investice ve výši 1 000 USD na 37 462 USD při reinvestování dividend, a to navzdory třem poklesům ceny akcií o více než 40 %.
Lam Research turned a modest stake into a life-changing sum over ten years, but the ride included three gut-wrenching collapses that pushed most investors to bail out long before the biggest gains arrived.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A $1,000 investment in Lam Research (NASDAQ:LRCX | LRCX Price Prediction) made 10 years ago would be worth about $37,462 today, measured through the Oct. 7, 2026 close. Every figure below assumes all dividends were reinvested in more shares. Getting there meant sitting through three separate drops of more than 40%.
Selling the Tools Behind Every Chip Boom Lam makes deposition, etch and clean systems that chipmakers use to build logic, DRAM and 3D NAND chips. Its sales track customer spending on new fab capacity, which moves with memory prices and chip inventories. Over the decade, Lam managed the 3D NAND transition, the 2017-2018 memory supercycle, a 2019 slump, the pandemic boom, a 2022-2023 memory bust with China export curbs, and now AI computing buildout.
AI demand shows up clearly in the results. Fiscal 2026 revenue hit a record $23.23 billion, up 26.0%. Management now expects 2026 industry equipment spending in the “low $150 billion range” and says “The industry is still meaningfully undersupplied.”
Your $1,000 Became $37,462 Lam’s price-only results appear in parentheses. The S&P 500 figures cover price change only.
1-Year Return
Initial Investment: $1,000 Current Value: $2,358.50 ($2,347.77) Total Return: 135.85% S&P 500 (same period): $1,161.60 (16.16%) 5-Year Return
Initial Investment: $1,000 Current Value: $37,461.80 ($32,836.07) Total Return: 3,646.18% Annualized Return: 43.67% S&P 500 (same period): $3,614.30 (261.43%, 13.71% annualized) Reinvesting dividends added about $4,626 over 10 years. Lam paid a dividend every quarter, rising from $0.30 in 2016 to $2.30 by September 2024, then $0.23 after the 10-for-1 split on Oct. 3, 2024, now $0.33. Reinvested shares bought during each slump still kept growing.
Based on closing prices, holders sat through a drop of about 50% from December 2021 to September 2022 and a 47% decline from July 2024 to April 2025. They also took a 42% fall between June 30 and July 29, 2026, which came right in the middle of record results.
Key Signals to Watch Before the Next 40% Drop The optimistic outlook holds if AI keeps the industry short on capacity through 2027 and Lam hits its targets of mid-50% gross margin and mid-40% operating margin. September quarter guidance calls for about $8.10 billion in revenue and $2.15 in EPS. The downside case gains weight if AI spending pauses or China export controls tighten. China made up 26% of June-quarter revenue.
Lam’s history carries a lesson for long-term holders. Over this decade, the return went to investors who held a cyclical stock through the whole cycle and kept reinvesting. Anyone who sold during the drawdowns gave up part of that gain (we studied a group of recent runners most investors walked past and pulled out the pattern in a free report: The Winners You Already Missed).
Contact [email protected] for any questions or corrections.
Watsco zveřejní hospodářské výsledky za třetí čtvrtletí roku 2026 před otevřením trhu 27. října; následovat bude konferenční hovor s vedením společnosti.
MIAMI, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Watsco, Inc. (NYSE: WSO) announced today that it has scheduled a conference call to discuss its 2026 third quarter results on Tuesday, October 27, 2026 at 10:00 a.m. (EDT). Prepared remarks regarding the results will be followed by a question-and-answer session with the senior management team.
The conference call will be webcast by CCBN's StreetEvents and can be found under the link highlighted on our website at www.watsco.com. The earnings results will be released before the market opens on October 27, 2026. A replay of the conference call will be available on our website.
Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will be given a unique PIN to gain immediate access to the call. Pre-registration may be completed at any time up to the call start time.
To pre-register, go to: https://dpregister.com/sreg/10212625/10511ca8502
Participants that would like to join, but have not pre-registered, can do so by dialing (844) 883-3908 within the United States or (412) 317-9254 internationally and asking for the “Watsco” call. Please call five to ten minutes prior to the scheduled start time as the number of telephone connections is limited.
Watsco is the largest distributor in the highly fragmented North American HVAC market. Since entering distribution in 1989, Watsco has achieved an 18% compounded annual total shareholder return through a combination of organic growth and the acquisition of more than 70 market-leading businesses.
Watsco maintains a solid balance sheet, enabling sustained investments in growth, including the Company’s industry-leading technologies. Today, more than 70,000 contractors and technicians engage digitally, empowering them to adopt and integrate Watsco’s tools into their daily operations. The Company is also introducing AI-driven initiatives to leverage its extensive data assets and enrich the customer experience. The Company believes its technology ecosystem represents a durable and widening competitive advantage in its highly fragmented industry.
Barry S. Logan
Executive Vice President
(305) 714-4102
e-mail: [email protected]
Wrap Technologies jmenovala Johna „Chappyho“ Chapmana viceprezidentem pro školení a nasazení, aby rozšířila škálovatelný systém školení a certifikace pro policejní složky.
MIAMI, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (“WRAP” or the “Company”), a provider of non-lethal response technologies and public safety solutions, today announced the appointment of John “Chappy” Chapman as Vice President of Training and Missions. Chapman brings more than three decades of law enforcement, tactical operations, instructional development, and leadership experience to WRAP as the Company expands its strategy to deliver comprehensive, scalable non-lethal response training programs across domestic and federal law enforcement.
In his new role, Chapman will oversee WRAP’s national training and mission integration strategy, including the implementation of a standardized four-level training and credentialing architecture, expansion of the Company’s digital Learning Management System (LMS), state Peace Officer Standards and Training (POST) certification initiatives, and agency-wide adoption of WRAP’s non-lethal response doctrine.
Chapman has been a principal author of WRAP’s non-lethal response doctrine, currently under review for POST certification in California, with additional state submissions anticipated. The doctrine is designed to bridge the operational gap between verbal de-escalation and physical arrest-and-control techniques, incorporating non-lethal response technologies such as the BolaWrap® 150 into a standardized framework for early intervention, restraint, and lawful subject control.
“We believe the opportunity in front of WRAP is much larger than the sale of a device,” said Jared Novick, President of Wrap Technologies. “We are building a national training and credentialing infrastructure that we believe allows law enforcement agencies to institutionalize non-lethal response as a repeatable capability. We believe Chappy has the operational experience, instructional expertise, and credibility to help us deliver that vision. His appointment is an important step in scaling our technology, doctrine, and training programs across law enforcement.”
A Four-Level Training Architecture Designed for National Scale
Under Chapman’s leadership, WRAP plans to advance a standardized four-level credentialing model designed to allow agencies to train and sustain their own personnel while maintaining consistent instructional standards.
Level 4 (L4) – Credentialing Board: WRAP’s credentialing authority responsible for certifying Level 3 master instructors and maintaining standards and oversight. The Level 4 resident course consists of five days, or 40 hours.Level 3 (L3) – Master Instructor: Senior instructors credentialed to develop and certify Level 2 instructors within their agencies or training organizations. The Level 3 resident course consists of five days, or 40 hours.Level 2 (L2) – Instructor: Agency-based instructors authorized to train and certify Level 1 users locally, reducing reliance on WRAP personnel for routine course delivery. The Level 2 resident course consists of three days, or 24 hours.Level 1 (L1) – Law Enforcement User: Frontline officers trained in the operational application of WRAP’s non-lethal response doctrine and technologies. The Level 1 program combines two hours of digital prerequisite learning with eight hours of in-person training, or a ten-hour fully resident alternative. The model is designed to scale through an instructor-development approach, enabling credentialed agency personnel to deliver standardized training within their own organizations.
For federal law enforcement agencies, the proposed architecture would allow WRAP to credential master instructors who subsequently develop instructors at federal training facilities and field offices. Those instructors could then train frontline personnel within their respective organizations, while WRAP retains responsibility for master instructor credentialing and instructional quality assurance.
The same architecture can support municipal police departments, sheriffs’ offices, state law enforcement agencies, and other public safety organizations seeking to integrate non-lethal response capabilities into patrol operations and existing training requirements.
Building a Scalable Commercial Model Around Training, Credentialing, and Digital Learning
WRAP’s training strategy is designed to extend beyond initial equipment deployment by establishing a repeatable commercial framework that supports agency implementation, digital learning, instructor development, and ongoing credential maintenance.
Digital Learning and Pre-Course Preparation: WRAP’s LMS will deliver standardized prerequisite coursework, including instructional videos and graded knowledge checkpoints, before officers attend resident training. This approach is intended to improve training consistency, reduce classroom time devoted to foundational material, and expand the Company’s ability to support geographically distributed agencies.
In-Person Training and Agency Implementation: WRAP will provide performance evaluation, instructor certification, and mission-specific implementation support. Agency-based instructors will then be positioned to train additional personnel locally, enabling adoption across larger organizations without requiring direct WRAP participation in every course.
Credentialing, Recertification, and Program Sustainment: WRAP’s framework establishes recurring credentialing and quality assurance requirements. Under the proposed standards, Level 1 users and Level 2 instructors recertify every two years, while Level 3 master instructors and Level 4 credentialing personnel recertify annually, with in-person requirements for the latter levels. The Company intends to develop commercial offerings around ongoing digital learning, credential management, instructor development, and program sustainment.
This approach is intended to support a scalable business model in which initial technology deployment can be complemented by training and implementation services, digital learning subscriptions, and recurring credentialing and sustainment opportunities, subject to agency procurement requirements and contractual arrangements.
Standardizing Non-Lethal Response Across Law Enforcement
WRAP’s non-lethal response doctrine is intended to help officers intervene earlier in an encounter when communication alone has not resolved resistance but circumstances may not require higher levels of force.
In ATF Ruling 2026-2, the Bureau of Alcohol, Tobacco, Firearms and Explosives determined that the BolaWrap 150 is not a “firearm” or “any other weapon” under the Gun Control Act or the National Firearms Act. The device is designed to provide officers with a remote restraint option that does not depend on pain compliance.
By integrating this capability into standardized training, WRAP seeks to help agencies establish a more complete operational continuum from verbal communication through physical custody, consistent with applicable law, agency policy, and officer judgment.
“Officers need options that work in the real world, and agencies need a way to train those options consistently,” said Chapman. “Our focus is on building a system that is teachable, measurable, and repeatable. From the patrol officer on the street to the federal instructor responsible for training hundreds of personnel, the standard must remain consistent. We want agencies to own and sustain the capability, supported by a doctrine and credentialing system they can trust.”
Decades of Operational and Instructional Experience
Chapman began his public safety career in 1992 following service in the United States Navy. His experience spans patrol operations, SWAT leadership, defensive tactics, firearms instruction, tactical curriculum development, and command responsibilities in government and private industry.
A certified POST instructor in 30 states and a Master POST instructor in several, Chapman has spent decades developing methodologies that translate complex operational skills into repeatable, measurable instruction.
He founded LMS Defense in 2004 and later co-founded Forge Tactical, contributing to the development of the Forge Tactical First Principles Close Quarters Battle doctrine. He also founded the Task Force 70 Foundation, a nonprofit dedicated to expanding training access for officers serving rural and small-town communities.
Chapman holds a bachelor’s degree in physical science and a master’s degree in homeland security.
Expanding WRAP’s Long-Term Market Opportunity
WRAP believes its integrated approach to non-lethal technology, standardized training, and digital credentialing can support broader institutional adoption across federal, state, and local law enforcement.
By enabling agencies to develop their own credentialed instructors, the Company seeks to reduce barriers to large-scale implementation while establishing opportunities for continuing education, curriculum updates, quality assurance, and recurring program engagement.
“Our strategy is to make non-lethal response a sustainable institutional capability, not a one-time training event,” added Novick. “That means combining technology with doctrine, instructor credentialing, digital learning, and ongoing support. We believe Chappy’s leadership will be instrumental in building the infrastructure to support that model and expand our reach across law enforcement.”
About Wrap Technologies, Inc.
Wrap Technologies, Inc. (NASDAQ: WRAP) is a public safety technology company focused on non-lethal response solutions, training, and integrated technologies designed to support law enforcement and security professionals. Through its BolaWrap family of remote restraint devices, training programs, and expanding technology portfolio, WRAP seeks to provide officers and agencies with additional options to manage encounters, support de-escalation, and improve public safety outcomes. For more information, visit www.wrap.com.
Forward Looking Statements
This press release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the Company’s adoption of a new law enforcement doctrine and training methodology, the Company’s California POST certification, the ability to digitize the Company’s training, the Company’s expectations regarding the impact and success of the Bola Wrap 150’s ATF classification, the Company’s potential to resolve crisis encounters, the capitalization and synergies expected from hiring Mr. Chapman, the expansion of LMS, the anticipated scaling of technology, doctrine, and training programs, the establishment of a repeatable commercial framework, the implementation of standardized training, and the broader institutional adoption of WRAP’s products across federal, state, and local law enforcement. Statements are based on current expectations and assumptions subject to risks and uncertainties, including the pace of customer and agency adoption, the timing and outcome of federal procurement and export control processes, the availability and terms of technology partnerships, regulatory developments, competitive conditions, and the Company’s ability to attract and retain personnel. Actual results could differ materially from those expressed or implied. WRAP undertakes no obligation to update or revise any forward-looking statement, and investors are cautioned not to place undue reliance on them.
Společnost Lumentum má optické komponenty vyprodané až do začátku roku 2029 kvůli poptávce po AI datacentrech; akcie LITE v pátečním předobchodním obchodování vzrostly o 6 %.
Shares of Lumentum Holdings LITE rose 6% in pre-market trading on Friday after Chief Executive Officer Michael Hurlston said demand for the company’s optical components had exceeded available supply, with orders booked through early 2029.
The company is struggling to keep pace with demand from technology firms expanding artificial intelligence data centres.
Hurlston told Bloomberg News in an interview in Tokyo that Lumentum was unable to meet a significant portion of customer demand and was working to expand production capacity.
Hurlston said Lumentum’s optical components were “completely sold out” through early 2029, adding that customers were already beginning to secure orders for 2030.
The company cannot meet around 70% of demand for some products through next year and expects to fall short of 30% of demand for certain other products through 2028, he said.
Lumentum supplies advanced indium phosphide devices used in high-speed data transmission and cloud computing.
Its technology is becoming increasingly important as AI workloads require faster connections between servers, data centre racks and computing systems.
The company’s products include lasers that encode data onto light near chips, reducing the distance that high-speed electrical signals need to travel.
Optical connections can also reduce power consumption and heat generation compared with conventional copper-based interconnects.
Hurlston said the opportunity could expand significantly as optical technologies move closer to AI accelerators.
Demand for lasers in next-generation AI systems is expected to gain traction around 2029, he added.
Lumentum received a $2 billion investment from Nvidia earlier this year, alongside a similar investment in rival Coherent.
The funding highlights the growing importance of optical technologies to AI infrastructure.
To meet demand, Lumentum has increased capacity at its Sagamihara facility in Japan twelvefold over the past two years.
The company plans to invest at least $350 million in the site and a neighbouring facility, with $75 million deployed so far. It has also expanded capacity at its plant in Caswell, England.
Hurlston said Lumentum was considering purchasing a facility in Japan and could seek subsidies to support further expansion.
The company may also need to consider an acquisition over the next year to broaden its product range.
However, increasing manufacturing capacity takes time.
Hurlston said building new production facilities typically requires three to five years.
He added that hyperscalers were willing to provide funding commitments that could help suppliers manage some of the risks associated with rapid expansion.
Lumentum and other optical component makers have benefited from the broader AI infrastructure investment boom, although concerns about rising costs, debt and competition have made some investors more cautious.
The company’s shares have gained 171% year to date. Coherent shares have risen 55%, while Applied Optoelectronics has advanced 66%.
Analyst sentiment on Lumentum remains positive overall. According to TipRanks data, 14 of 18 analysts covering Lumentum rate it a Buy, while the remaining four rate it a Hold.
Supply constraints could also affect the sector if the US restricts new Chinese optical transceiver models.
Chinese manufacturers account for roughly two-thirds of global high-speed AI optical transceiver supply, according to Counterpoint Research.
Hurlston said the US would need to balance national security concerns against the risk of disrupting supply chains.
Meanwhile, Lumentum faces the challenge of expanding production quickly enough to serve customers as demand for AI infrastructure continues to grow.
Nový ruční diagnostický přístroj Apollo ve druhém čtvrtletí 2026 podpořil poptávku po produktech Snap-on mezi nezávislými autoservisy; databáze SureTrack zahrnuje 660 miliard záznamů o vozidlech.
Key Takeaways SNA's Apollo handheld diagnostic unit drove strength in independent repair shops during the second quarter.Apollo offers guided diagnostics, broad vehicle coverage and a database of 660 billion vehicle events.SNA reports strong Apollo orders and van-channel sales, and power tools & torque drive strategic pivot growth. Snap-on Incorporated (SNA - Free Report) reported encouraging demand for its newly launched Apollo handheld diagnostic unit in the second quarter of 2026. Management identified Apollo as a key contributor to the strength of independent repair shops within its Repair Systems and Information (RS&I) business, highlighting the product's promising early performance.
Apollo provides an entry point for technicians seeking intelligent diagnostics at a moderate cost. Its features include proprietary information, broad manufacturer and model coverage, and guided diagnostic workflows. Its SureTrack database contains 660 billion vehicle events and 3.4 billion repair records. Improved display visibility, extended battery life, wireless vehicle connectivity and increased storage are designed to improve usability and speed. Sales through Snap-on's van channel were strong, and management reported robust momentum following the launch.
Management noted that Apollo received a strong order and achieved a stronger launch than it historically had relative to other diagnostic products. Although positioned at the entry level of intelligent diagnostics, Apollo remains expensive, and its previous launches were generally less successful than those of other diagnostic products. The latest launch was therefore encouraging and contributed to the strength of the independent repair shop business.
However, management clarified that Apollo was not a product associated with the company's strategic pivot, as its launch would have proceeded regardless of that initiative. By contrast, management directly linked growth in power tools and torque products to the pivot, estimating that pivot-related products accounted for two-thirds or more of the overall growth.
Overall, Apollo's strong launch and continued sales momentum provide encouraging signs for its contribution to Snap-on's diagnostic business, particularly among independent repair shops.
The Zacks Rundown for SNASnap-on’s shares have lost 10.7% in the past three months compared with the industry’s 6.1% decline.
Image Source: Zacks Investment Research
From a valuation standpoint, SNA trades at a forward price-to-earnings ratio of 17.24 compared with the industry’s average of 17.80. The company currently carries a Zacks Rank #3 (Hold).
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for SNA’s current and next fiscal-year sales and earnings implies a rise of 1.1% and 7.3%, respectively, from the previous year figures.
Image Source: Zacks Investment Research
Stocks to ConsiderSome better-ranked stocks have been discussed below:
Carter’s, Inc. (CRI - Free Report) designs, sources and markets branded children's wear in the United States and internationally. At present, CRI carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for CRI’s current fiscal-year sales implies growth of 3.1%, while the same for earnings implies a decline of 5.5% from the year-ago figures. CRI delivered a trailing four-quarter earnings surprise of 415.9%, on average.
Kontoor Brands, Inc. (KTB - Free Report) , a lifestyle apparel company, designs, manufactures, procures, sells and licenses apparel, footwear and accessories, primarily under the Wrangler, Lee, and Helly Hansen brands. At present, KTB carries a Zacks Rank of 2.
The Zacks Consensus Estimate for KTB’s current fiscal-year sales and earnings implies a decline of 14.3% and 6.1%, respectively, from the year-ago figures. KTB delivered a trailing four-quarter earnings surprise of 21.4%, on average.
The Toro Company (TTC - Free Report) provides professional turf maintenance equipment and services. It operates through Professional and Residential segments. At present, TTC carries a Zacks Rank of 2.
The Zacks Consensus Estimate for TTC’s current fiscal-year sales and earnings implies growth of 6.5% and 10.5%, respectively, from the year-ago figures. TTC delivered a trailing four-quarter earnings surprise of 7.2% on average.
Společnost Microchip Technology koupila VORAGO Technologies, výrobce radiačně odolných mikrokontrolérů a mikroprocesorů pro vesmírné, obranné a průmyslové použití. Podmínky transakce nebyly zveřejněny.
Acquisition Complements Microchip's Aerospace, Defense and Space Solution Portfolio with Radiation-Hardened Microcontrollers and Patented Process Technology | Source: Microchip Technology Inc.
CHANDLER, Ariz., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Microchip Technology Incorporated (Nasdaq: MCHP), a broadline supplier of semiconductors committed to making innovative design easier through total system solutions, today announced that it has acquired VORAGO Technologies, Inc., a privately held provider of radiation-hardened and radiation-tolerant microcontrollers (MCUs) and microprocessors (MPUs), based in Austin, Texas. Terms of the transaction were not disclosed, and the acquisition is not expected to be material to Microchip's consolidated financial results.
"From terrestrial defense systems to satellite and space-based platforms, our aerospace and defense customers are designing systems that must operate reliably in increasingly harsh and complex environments," said Steve Sanghi, Microchip's CEO and President. “The acquisition of VORAGO strengthens our ability to support development in these demanding markets and reinforces our commitment to investing in technologies that align with our long-term growth strategy.”
The acquisition adds a family of radiation-hardened MCUs and MPUs that complement Microchip's existing aerospace and defense product lines, along with VORAGO's patented HARDSIL® process technology. HARDSIL helps reduce the design time and cost of developing new rad-hard products and can enhance the radiation tolerance of existing products without a redesign. With this acquisition, Microchip is positioned to capture a larger share of the A&D and space markets, which have seen accelerating investment and demand across both defense and commercial space programs. The transaction also strengthens Microchip’s technical capabilities through the addition of a team with deep radiation-hardening expertise that can be leveraged across the company’s broader business.
VORAGO's MCUs are designed to keep working where standard electronics fail, tolerating high radiation exposure and extreme heat, which makes them well suited for mission-critical space, defense and industrial applications.
“VORAGO has always been focused on delivering the best radiation-protected semiconductor solutions that customers can depend on when failure is not an option. Joining Microchip gives us the opportunity to build on that foundation with greater scale, broader capabilities and the resources to serve a rapidly growing space market. I’m proud of what our team has built, and excited for how this acquisition can empower our customers to execute missions faster and with very high confidence,” said Bernd Lienhard, Chief Executive Officer of VORAGO Technologies.
Cautionary Statement:
Certain statements in this release, including that the acquisition is not expected to be material to Microchip's consolidated financial results; that customers are designing systems that must operate reliably in increasingly harsh and complex environments; that the acquisition of VORAGO strengthens our ability to support development in these demanding markets and reinforces our commitment to investing in technologies that align with our long-term growth strategy; that the acquisition adds a family of radiation-hardened MCUs and MPUs that complement Microchip's existing aerospace and defense product lines; that HARDSIL helps reduce the design time and cost of developing new rad-hard products and can enhance the radiation tolerance of existing products without a redesign; that Microchip is positioned to capture a larger share of the A&D and space markets, which have seen accelerating investment and demand across both defense and commercial space programs; that he transaction also strengthens Microchip’s technical capabilities through the addition of a team with deep radiation-hardening expertise that can be leveraged across the company’s broader business; that VORAGO's MCUs are designed to keep working where standard electronics fail, tolerating high radiation exposure and extreme heat, which makes them well suited for mission-critical space, defense and industrial applications; that joining Microchip gives the opportunity to build on that foundation with greater scale, broader capabilities and the resources to serve a rapidly growing space market; and that this acquisition can empower our customers to execute missions faster and with very high confidence are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause our actual results to differ materially, including, but not limited to: any economic uncertainty due to monetary policy, geopolitical or other issues in the U.S. or internationally, any unexpected fluctuations or weakness in the U.S. and global economies; changes in demand or market acceptance of our products (including Vorago products) and the products of our customers; the mix of inventory we hold and our ability to satisfy short-term orders from our inventory; changes in utilization of our manufacturing capacity and our ability to effectively manage our production levels; competitive developments including pricing pressures; the level of orders that are received and can be shipped in a quarter; changes or fluctuations in customer order patterns and seasonality; our ability to successfully integrate the operations and employees, retain key employees and customers and otherwise realize the expected synergies and benefits of the Vorago acquisition; our ability to obtain a sufficient supply of wafers from third party wafer foundries and the cost of such wafers, the costs and outcome of any current or future tax audit or any litigation involving intellectual property, customers or other issues; disruptions in our business or the businesses of our customers or suppliers due to natural disasters, terrorist activity, armed conflict, war, worldwide oil prices and supply, public health concerns or disruptions in the transportation system; and general economic, industry or political conditions in the United States or internationally. For a detailed discussion of these and other risk factors, please refer to the SEC filings of Microchip including those on Forms 10-K, 10-Q and 8-K.
You can obtain copies of such filings and other relevant documents for free at Microchip's website (www.microchip.com) or the SEC's website (www.sec.gov) or from commercial document retrieval services.
Stockholders are cautioned not to place undue reliance on the forward-looking statements in this press release, which speak only as of the date such statements are made. Microchip undertakes no obligation to publicly update any forward-looking statements to reflect events, circumstances or new information after the date of this press release, or to reflect the occurrence of unanticipated events.
About Microchip Technology:
Microchip Technology Inc. is a broadline supplier of semiconductors committed to making innovative design easier through total system solutions that address critical challenges at the intersection of emerging technologies and durable end markets. Its easy-to-use development tools and comprehensive product portfolio supports customers throughout the design process, from concept to completion. Headquartered in Chandler, Arizona, Microchip offers outstanding technical support and delivers solutions across the industrial, automotive, consumer, aerospace and defense, communications and computing markets. For more information, visit the Microchip website at www.microchip.com.
About VORAGO Technologies:
Founded in 2004, VORAGO Technologies designs and manufactures radiation-hardened and extreme-temperature (up to 200°C) microcontrollers primarily for the space and industrial markets, and licenses its patented HARDSIL technology. The company is headquartered in Austin, Texas.
Note: The Microchip name and logo and the Microchip logo are registered trademarks of Microchip Technology Incorporated in the U.S.A. and other countries. All other trademarks mentioned herein are the property of their respective companies.
Crown Holdings by měl ve 3. čtvrtletí vykázat zisk 2,26 USD na akcii a tržby ve výši 3,45 mld. USD, oproti 2,24 USD na akcii a 3,2 mld. USD ve stejném období loňského roku.
Crown Holdings, Inc. (NYSE:CCK) will release earnings for its third quarter after the closing bell on Monday, Oct. 19.
Analysts expect the Tampa, Florida-based company to report quarterly earnings of $2.26 per share, up from $2.24 per share in the year-ago period. The consensus estimate for CCK’s quarterly revenue is $3.45 billion. It reported $3.2 billion last year, according to Benzinga Pro.
On July 20, Crown Holdings reported better-than-expected second-quarter financial results and raised its FY26 earnings guidance.
Crown Holdings shares gained 1.7% to close at $108.88 on Thursday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
UBS analyst Joshua Spector maintained a Neutral rating and cut the price target from $123 to $116 on Oct. 5, 2026. This analyst has an accuracy rate of 60%. JP Morgan analyst Jeffrey Zekauskas upgraded the stock from Neutral to Overweight with a price target of $121 on Sept. 18, 2026. This analyst has an accuracy rate of 65%. RBC Capital analyst Arun Viswanathan maintained the stock with an Outperform rating and raised the price target from $131 to $135 on July 24, 2026. This analyst has an accuracy rate of 52%. Wells Fargo analyst Gabe Hajde maintained an Equal-Weight rating and raised the price target from $117 to $127 on July 22, 2026. This analyst has an accuracy rate of 77%. Truist Securities analyst Michael Roxland maintained the stock with a Buy rating and increased the price target from $129 to $141 on July 22, 2026. This analyst has an accuracy rate of 54%. Considering buying CCK stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Fifth Third Bancorp (NYSE:FITB) will release its third-quarter earnings report before the opening bell on Monday, Oct. 19.
Analysts expect the Cincinnati, Ohio-based company to report quarterly earnings of 81 cents per share, down from 91 cents per share in the year-ago period. The consensus estimate for FITB’s quarterly revenue is $3.34 billion. It reported $2.31 billion last year, according to Benzinga Pro.
On Sept. 17, Fifth Third Bancorp increased its quarterly dividend from 40 cents to 42 cents per share.
Fifth Third Bancorp shares gained 1.2% to close at $50.70 on Thursday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
UBS analyst Erika Najarian maintained a Buy rating and cut the price target from $65 to $63 on Oct. 5, 2026. This analyst has an accuracy rate of 63%. JP Morgan analyst Vivek Juneja maintained an Overweight rating and cut the price target from $62 to $58 on Oct. 2, 2026. This analyst has an accuracy rate of 57%. Evercore ISI Group analyst John Pancari maintained an In-Line rating and slashed the price target from $61 to $57 on Oct. 1, 2026. This analyst has an accuracy rate of 61%. Truist Securities analyst Brian Foran maintained the stock with a Buy rating and lowered the price target from $64 to $63 on Sept. 23, 2026. This analyst has an accuracy rate of 61%. B of A Securities analyst Ebrahim Poonawala maintained a Buy rating and raised the price target from $63 to $65 on July 20, 2026. This analyst has an accuracy rate of 67%. Considering buying FITB stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
PNC 20. října 2026 odkoupí veškeré seniorní dluhopisy s kupónovou sazbou 6,615 % se splatností v roce 2027 o celkovém objemu 1,25 miliardy USD za 100 % jmenovité hodnoty plus naběhlý úrok.
, /PRNewswire/ -- The PNC Financial Services Group, Inc. (NYSE: PNC) today announced the redemption on Oct. 20, 2026, of all outstanding 6.615% Fixed Rate/Floating Rate Senior Notes due Oct. 20, 2027, issued by PNC in the amount of $1,250,000,000 (CUSIP 693475 BT1). The securities have an original scheduled maturity date of Oct. 20, 2027. The redemption price will be equal to 100% of the principal amount, plus any accrued and unpaid interest to the redemption date of Oct. 20, 2026. Interest on the 6.615% Fixed Rate/Floating Rate Senior Notes will cease to accrue on the redemption date.
Payment of the redemption price for the 6.615% Fixed Rate/Floating Rate Senior Notes will be made through the facilities of The Depository Trust Company.
The PNC Financial Services Group, Inc. is one of the largest diversified financial services institutions in the United States, organized around its customers and communities for strong relationships and local delivery of retail and business banking including a full range of lending products; specialized services for corporations and government entities, including corporate banking, real estate finance and asset-based lending; wealth management and asset management. For information about PNC, visit www.pnc.com.
